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EXECUTIVE SUMMARY 
 
This technical report outlines the issues in measuring outcome in the alcohol and 
other drug field. It provides a review of the measures that are currently available. 
 
Introduction 
 
♦ Outcome is defined as the effect on an individual’s health status that is attributable 
to an intervention. 
 
♦ The potential clients are the 10% of the population who will meet criteria for an 
alcohol or other drug use disorder in the past 12 months. Only a third of the 
potential clients seek treatment in any year. Three quarters of those who seek 
treatment are seen by general practitioners. 
 
♦ Outcome measurement is of importance to clients, clinicians and administrators. 
 
♦ The standard measurement of outcome is likely to improve treatment. 
 
♦ Outcome measures are reviewed in regard to their applicability, acceptability, 
practicality, reliability, validity and sensitivity to change. The advantages and 
disadvantages of self -report and clinician rated measures are discussed. 
 
♦ Outcome measures are commonly cited in the literature. Measures that are brief, 
low in cost, multi-dimensional and require little training, are likely to be most 
suitable for use in routine clinical services. 
 
Methodology 
 
♦ Consultation: A brief survey was conducted of 50 government and non- 
government alcohol and other drug treatment services 
 
♦ Literature: A keyword search on Medline, Psych Info, Embase and Web of 
Science was conducted. Outcome measures were also identified from specialist 
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texts and the citation lists of published treatment outcome studies in the alcohol 
and other drug field. Over 300 measures were examined as possible outcome 
measures. Of those, 44 were selected for examination and review by two 
independent raters. These measures include those designed for and used in  
adolescent populations. 
 
Results 
 
♦ Consultation: Consultation with the field showed that ‘use of alcohol or other 
drugs’ and ‘functioning’ are viewed as the most important areas of outcome 
measurement. ‘Questionnaire’ or ‘interview with the client’ were rated as the 
preferred methods, and respondents stated that the collection of such data would 
improve service efficacy.  
 
♦ Literature Review: The 44 measures reviewed covered the following areas: 
‘screening of problematic use and quantity/frequency’, ‘diagnosis of 
dependence/harmful use’, ‘relapse’, ‘functioning’, ‘multi-dimensional’ and 
‘satisfaction with service’.Measures were reviewed in regard to their applicability, 
acceptability, practicality, reliability, validity and sensitivity to change. 
 
Recommendations 
 
♦ Four measures met minimum criteria for use as routine outcome measures: 
Addiction Severity Index (ASI), Health of the National Outcome Scale (HoNOS), 
Opiate Treatment Index (OTI) and Short Form-36 (SF-36). 
♦ The Opiate Treatment Index is a measure developed in Australia and meets all the 
requirements. It is recommended that it be revised and shortened for use as a 
routine outcome assessment tool. 
 
Conclusion 
 
♦ Outcome is important for clients, clinicians and managers. This report provides a 
review of instruments currently used to assess outcome in the alcohol and other 
drug field. 
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INTRODUCTION 
 
The primary aim of any health care service is to have a positive impact on the health 
and wellbeing of its clients. The routine and systematic measurement of ‘treatment 
outcome’, is gaining increased attention. This issue is now firmly on the agenda with 
the advent of managed care in the USA. In Australia at present there is no agreed 
measures of treatment outcome in alcohol and other drug treatment settings. This 
technical report addresses the issue of how progress towards measurement of client 
outcomes might be achieved. 
 
Background to the Study: The National Minimum Data Set 
 
In Australia, an ongoing data collection system will commence on the first of July 
2000 as agreed by all States and Territories.  This project was borne out of a national 
forum conducted in 1995 by the Alcohol and Other Drugs Council of Australia that 
examined barriers between research and practice within the alcohol and other drug 
(AOD) field. The aim of the project was to design a national framework for collection 
of consistent data across all treatment services (Conroy & Copeland, 1998). This 
collection is known as the ‘National Minimum Data Set on Clients of Alcohol and 
Other Drug Treatment Services (NMDS:CAODTS)’.  The objectives of the NMDS: 
CAODTS are to: 
• monitor broad patterns of service utilisation; 
• monitor access to services for specific population groups; 
• inform planning and development of service delivery strategies; and 
• support the development of benchmarking. 
  
In 1998 The National Drug and Alcohol Research Centre (NDARC) developed and 
piloted, in consultation with treatment agencies, a set of data items for national 
collection. The Commonwealth funded the Australian Institute of Health and Welfare 
(AIHW) as the national collection agency for the data set. Throughout 1999, under the 
management of the AIHW, substantial modifications were made to the data domains 
and definitions of the proposed items. Due to inherent difficulties in the modified 
design of the data set, only a subset of the original proposal is to be collected 
nationally from July of this year.  
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This subset will contain information on client demographics and drug use. It will not 
however contain information pertaining to the treatment services provided by 
treatment agencies. Unfortunately, due to the modifications, the items to be collected 
nationally are not consistent with those that were presented in the NDARC Technical 
Report No. 65, which resulted from the 1998 pilot study. The potential for the further 
development and expansion of the NMDS-CAODTS is currently being explored by a 
working group of the Inter-Governmental Committee on Drugs. 
 
The NSW Monitoring and Outcomes Project 
 
Within New South Wales, NDARC is involved in a partnership with the NSW Health 
Department – the Monitoring and Outcomes Project (MOP). The major goals of this 
project are to establish a statewide treatment data set, and following this, to introduce 
the regular assessment of treatment outcomes using a brief outcome instrument.  
 
This project will provide data on the drug and alcohol services available, the 
utilisation of these services, client population profiles, treatment needs, the types of 
treatment delivered and outcomes achieved. This information will serve to facilitate 
increased awareness and improved responses to relevant issues by the government, 
treatment and other health agencies, and the broader community. 
 
Collection of the NSW Minimum Data Set will also formally commence in July this 
year. The data set being collected includes all of the data items agreed to nationally, 
as well as additional items to describe the treatment services being provided. 
Definitions of these data items are available in the Data Dictionary for Alcohol and 
Other Drug treatment Services in New South Wales. A ‘ready reference’ version of 
this dictionary is also being developed, and training sessions will be conducted in 
various regions of New South Wales.  
 
The next stage of the MOP project is the addition of an outcomes section to the data 
collection. A review of outcome measures is a necessary progression from this aim. 
Currently there is no standard protocol for measuring outcome in the alcohol and 
other drug field. This technical report reviews the literature on outcome measures and 
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makes recommendations as to how progress towards the routine measurement of 
outcome might be made. 
 
What is ‘outcome’? 
 
In 1994 the Australian Health Ministers Advisory Council Health Outcomes Seminar 
agreed that ‘a health outcome is a change in the health of an individual, or group of 
people or population which is attributable to an intervention or series of interventions’ 
(AHMAC, 1993). The key aspect of health outcomes as defined here is that change is 
attributable to the intervention used. For aggregate data the overall effect should be 
improvement. However on an individual basis the expectation of measurable change 
may be unrealistic. The outcome of good treatment for some individuals may be 
maintenance of a given level of functioning rather than measurable improvement in 
functioning.  
 
The outcome of detoxification treatment for a homeless person withdrawing from 
opiates or alcohol may be markedly different from the outcome achieved with a 
young person detoxing for the first time with the full emotional and financial 
resources of parents and family. Accordingly it may then be more appropriate to think 
of and define treatment outcome as an EFFECT on the health of an individual, group 
of people or population, which is attributable to an intervention or series of 
interventions (Andrews et al., 1994).    
 
Outcome is: 
The effect on an individuals health status that can be attributed to a treatment 
intervention. 
 
Who are the clients? 
 
It is important to understand the basic profile of the clients of alcohol and other drug 
services, in order to choose the most meaningful outcomes and measures for this 
group. Who are the clients to whom measurement of outcome should apply? Whilst 
clients with an alcohol or other drug problem cut through the entire spectrum of 
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society it is helpful first to look at the extent of the problem in terms of the 
percentages of the population that will suffer from an alcohol and other drug use 
disorder in any year. 
 
The National Survey of Mental Health and Wellbeing can provide information on the 
nature and extent of  substance use disorders in Australia. The National Survey of 
Mental Health and Well-Being (NSMHWB) (ABS.,1998) is a nationally 
representative survey of 10641 Australians. Disorders were defined in terms of ICD-
10 (World, 1993) and DSM-IV diagnostic criteria (Diagnostic and statistical manual 
of mental disorders, 1994). 
 
The NMHWB survey found that one in thirteen Australian adults aged 18 years and 
older (7.7%) had a substance use disorder according to ICD-10 criteria (World, 1993) 
in the past 12 months. Males were about twice as likely as females to have a 
substance use disorder; 11.1% of males and 4.5% of females met criteria for the 
diagnosis of a substance use disorder in the past 12 months. 
 
Substance abuse is a term that covers both abuse of alcohol and abuse of other drugs. 
The NSMHWB survey provides specific information on the each of these areas as 
follows: 
 
Alcohol use disorders 
 
A large proportion of the Australian adults sampled (83% of males and 63% of 
females) reported that they had consumed at least 12 drinks of alcohol in the 
preceding year. One in fifteen (6.5%) met criteria for an alcohol use disorder in the 
past 12 months. Three percent reported harmful use (4.3% of males and 1.8% of 
females) and 3.5% could be classified as alcohol dependent (5.2% of males and 1.8% 
of females). A greater number of males than females had an alcohol use disorder 
within the past 12 months (9.4% versus 3.7% respectively).   
 
The majority of persons meeting criteria for alcohol dependence (96%) reported 
impaired control over their alcohol use, indicating greater use or using for longer than 
intended, or by a persistent desire or unsuccessful efforts to cut down.  Of those with 
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alcohol dependence three in four persons (73%) reported tolerance to the effects of 
alcohol but only half (50%) reported having experienced either withdrawal symptoms 
from alcohol, or having used alcohol to avoid or relieve withdrawal symptoms 
(Teesson, Hall, Lynsky, & Degenhardt, 2000). 
 
Other drug use disorders 
 
Of the other drugs used (cannabis, stimulants, sedatives and opioids), one in eight 
males (12.5%) and one in fourteen females (6.9%) reported that they had used at least 
one of these drugs more than five times in the past year.  Cannabis was the most 
commonly reported drug in this class, used by 10.3% of males and 4.3% of females. 
Stimulant, sedative and opioid use was reported by 1.3 - 1.9% of males, and 0.6 - 
2.3% of females. 
 
About 1 in 45 persons were affected by drug use disorders in the past 12 months. An 
estimated 2.2% of the Australian adult population met criteria for a drug use disorder 
(0.2% with harmful use, and 2.0% with dependence) on at least one of these 
controlled substances in the last 12 months. Cannabis accounted for most drug use 
disorders: 1.7% of the sample met criteria for a 12 month diagnosis of a cannabis use 
disorder.  Sedative use disorders affected 0.4% of the study population, while 0.3% 
could be diagnosed with a stimulant use disorder. In addition 0.2% met criteria for an 
opioid use disorder in the past 12 months.  
 
The NSMHWB, being a household survey will be likely to under-represent the extent 
of heroin dependence in the community. The NSMHWB estimated opioid dependence 
in the past 12 months as 0.2% or 2 per 1000. Hall, Lynsky, & Degenhardt (1999) state 
" Indirect estimates of the prevalence of heroin dependence produce higher estimates. 
These are provided by multiplying the number of dependent heroin users who are 
identified from a particular source by a factor thought to represent the ratio of known 
to unknown dependent heroin users. These estimates, and a consensus of experts in 
the field, suggest that there were approximately 100 000 dependent heroin users in 
Australia in the late 1990s (0.7% of adults)." 
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Co-morbidity 
 
Forty-eight per cent of females with an alcohol use disorder met criteria for an 
anxiety, affective or drug use disorder compared with 15% in the ‘non-drug use 
disordered’ general female population. One third of males with an alcohol use 
disorder met criteria for a mental health disorder compared with 9% in the general 
male population. 
 
There is also a moderate degree of co-morbidity between substance use disorders and 
other common mental health problems. According to the NHSMHWB 65% (two 
thirds) of females with a drug use disorder met criteria for an anxiety, affective or 
alcohol use disorder. These rates contrast markedly with the females without a drug 
use disorder of whom only 12% met criteria for a mental health diagnosis. 
 
The figures were similar for males with 64% meeting criteria for a mental health 
disorder, compared with only 11% of men without a drug use disorder meeting similar 
criteria. Forty-two per cent of individuals with a drug use disorder had a co-morbid 
physical disorder.   
 
Who seeks/receives treatment? 
 
The NSMHWB (1998) found, as did the Epidemiological Catchment Area survey 
(Regier et al., 1990) and the National Co-morbidity Survey (Kessler et al., 1994), that 
only a minority of those who meet criteria for an alcohol and drug use disorder had 
sought professional help for their condition (21% of women and 12% of men). 
Treatment seeking was related to gender, with females being more likely to seek 
assistance than males. Among those who sought help, general practitioners were the 
health professionals most likely to be consulted. 
 
In other words the survey findings do not necessarily mean that 6.5% of Australian 
adults need specialist treatment for alcohol use disorders (Teesson et al., 2000). 
Specialist treatment is one response that should form part of a general public health 
approach to reducing alcohol and other drug use disorders (Teesson et al., 2000). 
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Public health policies that reduce the availability and increase the price of alcohol 
may also reduce the prevalence of alcohol use disorders (Walsh & Hingson, 1987).  
 
Screening and brief advice for excessive alcohol consumption in general practice and 
hospital settings has been shown to reduce consumption and the problems caused by 
alcohol (Wilk, Jensen, & Havighurst, 1997;Nathan & Gorman, 1998). Screening is of 
considerable importance for males who were unlikely to seek assistance in the present 
survey (Teesson et al., 2000). The focus of this report is not the measurement of the 
outcome of these public health approaches but rather the measurement of the outcome 
for individuals who seek specialist treatment. It is important to note that the efficacy 
of treatments have been demonstrated in the literature.   
 
Does treatment work? 
 
Of those who have sought treatment in the past, controlled evaluations have 
demonstrated that about a third of patients remain abstinent over a year, a third show 
reductions in their drinking, while the drinking in the remaining third is largely 
unchanged (Mattick & Jarvis, 1993).  
 
There is also good evidence that treatment for alcohol dependence has a net economic 
benefit. Holder & Blose (1986) & Holder & Schachman (1987) show a substantial 
reduction in health care expenditure of insured persons between the three years before 
and the three years after alcohol treatment. More recently new pharmacological 
treatments such as acamprosate and naltrexone have proven to be effective in 
preventing relapse in people with alcohol dependence (Whitworth, 1996;Volpicelli, 
1992). 
 
Several studies in both the USA and the UK have established the efficacy of treatment 
for substance use disorders more broadly; DATOS (Hubbard, Craddock, Flynn, 
Anderson, & Ethridge, 1997) CALDATA(Gerstein, Johnson, Harwood, Suter, & 
Malloy, 1994) & NTORS; (Gossop, Marsden, & Stewart, 1998)). 
 
The Drug Abuse Treatment Outcome Study (DATOS) was a national community-
based treatment outcome study conducted in the United States (Flynn, Craddock, 
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Hubbard, Anderson, & Etheridge, 1997b). In this study 10 010 individuals undergoing 
treatment were sampled. Of this total, 4229 were interviewed 12 months following 
treatment. Outpatient methadone maintenance, long-term residential treatment, 
outpatient drug-free treatment and private/public short-term residential treatment were 
the four major treatments offered. Significant reductions in most types of drug use 
across all treatments were recorded. Reduced crime and increased employment in the 
long-term residential treatment group and improved long-term employment and 
reduced suicidal ideation in the outpatient drug-free group were also found.  
 
The California Drug and Alcohol Treatment Assessment Project (CALDATA) was 
another large scale pre-treatment post-treatment study of the effectiveness, cost 
effectiveness and overall economic value to society of drug and alcohol treatment in 
America (Gerstein et al., 1994). 3055 individuals were selected to participate in this 
study. These subjects were recruited from the following treatment modalities: 
residential programs, social model recovery houses, outpatient non-methadone, 
methadone maintenance, and detoxification (both residential and outpatient). 1859 
individuals were included in a follow-up study on an average of 15 months following 
treatment. Reductions in drug use among 40% of subjects, a 17% improvement in 
self-reported health, and a decrease in hospitalisation were found. The study 
concluded that treatment is effective.  
 
Recent data on outcome has also come from the United Kingdom. The National 
Treatment Outcome Study (NTORS;Gossop et al., 1998) was the first broadly based 
study in the United Kingdom aimed at examining outcomes for primary illicit drug 
problems at multiple sites: specialist inpatient treatment, rehabilitation programs, 
methadone maintenance and methadone reduction programs. 1075 clients were 
recruited for this study. 753 of these were followed-up at one year following treatment 
initiation. At 12-month follow-up results indicated that clients in all treatment 
modalities had substantially reduced their use of illicit drugs. A number of 
improvements in both their physical and mental health were recorded, as was a 
substantial reduction in their involvement in criminal activity.  
 
Clearly treatment can be effective with this population. Treatment services work. 
Providing treatment is undoubtedly crucial in order to assist people to recover from 
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AOD use and their associated problems and subsequently reducing the burden of such 
problems to the community. However treatment provision is not sufficient on its own. 
Once treatment has been delivered it must then be evaluated in order to ensure that 
treatment is effective and that it is meeting the needs of the target population. Such 
evaluation is a component of good clinical practice - providing feedback to clinicians 
about their practises. Evaluation is also important, in order to truly gauge the cost 
effectiveness of such treatment services. But exactly what outcomes are important and 
therefore necessary to measure and how do we measure those outcomes?  
 
What outcomes should be measured in drug and alcohol? 
 
As outlined above, one of the main purposes of evaluation is to attribute outcome in 
the client to a treatment intervention. Measuring outcome in health is not a new 
concept. Traditionally there has been a tendency to measure outcome in terms of input 
and process. Quality assurance programs have often measured outcome by measuring 
the amount of treatment resources (capital and staff) resources provided (input) and 
the number of treatment occasions provided (level of service or process) (Jenkins, 
1990). In other words an increase in the provision of resources has traditionally been 
equated with an improvement in the health of consumers.  This is an erroneous 
assumption (Solomon, Buckingham, & Epstein, 1993). 
 
Input and process cannot be ignored when evaluating outcome. It is important to 
improve processes and set standards for best practice, but this alone does not ensure a 
beneficial outcome. It is only by determining what effects on health and functioning 
the treatment aims to achieve, and then by measuring if such effects have taken place 
as a result of treatment, that outcome can be truly gauged. 
 
It is vital at this point to discuss the nature of health effects or outcomes that need to 
be assessed. Before this can be done it is important to note the difficulties involved in 
attributing change in an individual to the receipt/consumption of treatment. 
 
There are 3 basic factors that can lead to the mistaken belief that an improvement in 
functioning occurred as the result of treatment. The first of these is called regression 
to the mean (Andrews et al., 1994). Regression to the mean describes an improvement 
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that occurs as a normal fluctuation in the course of a disorder. Research has shown 
that disorders fluctuate. Individuals usually seek treatment when the symptoms of 
their condition are most severe, and so an improvement after treatment may simply 
have occurred without treatment, in the normal course of fluctuations in their health. 
 
The second factor that can lead to improvement in functioning regardless of treatment 
is spontaneous remission (Cook & Campbell, 1979). Spontaneous remission occurs 
with some illnesses whereby the individual recovers due to non-specific variables that 
are not in any way related to treatment; internal biological improvements, external 
environmental improvements. 
 
Finally the placebo effect can lead to an improvement in client functioning (Andrews 
et al., 1994). This is the general effect of receiving treatment, rather than a specific 
effect of a particular treatment. Receiving treatment, even a placebo can lead to a 
positive outcome in functioning, simply because the client is encouraged and becomes 
motivated to try harder to recover and report the expected gains. 
 
Essentially randomised-controlled trials are the most stringent way of controlling for 
or, at least minimising, these errors, which attribute change to treatment rather than 
the three factors actually responsible for the change as outlined above. Obviously not 
all treatment can undergo such cost and labour intensive procedures as randomised 
control trials.  
 
It is essential to develop ways of monitoring outcome that; 1) manage to minimise the 
above errors, 2) acknowledge input and process, without relying exclusively on these, 
and 3) measure the real effect of the treatment on the client and how this compares 
with the goals of treatment for each client. This leads to a discussion of the measures 
that have often been used in the past to evaluate change in clients with an alcohol or 
drug problem. 
 
Traditionally, treatment outcome measurement in the alcohol and other drug services 
has focussed on the drug and alcohol use of an individual. However implicit in the 
notion of harm minimisation is the idea that it is not just the use of alcohol and drugs 
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that should be attended to, but also the consequences of their use, especially with 
regard to the ability of the individual to function in the community.  
 
Levels of functioning and quality of life form the core constructs of disability and, 
therefore are likely to be part of most measures of consumer outcome. Factors such as 
an individual’s ability to attend to self-hygiene and maintain employment and social 
relationships need to be assessed, in order to demonstrate the efficacy of a particular 
treatment. Similarly an individual’s ability to derive pleasure and satisfaction from 
his/her existence is another area that can reflect the effectiveness of treatment. 
Satisfaction with treatment too can impact upon the recovery of the individual.  
 
The World Health Organisation's (WHO) International Classification of Impairments, 
Disabilities and Handicaps (ICIDH) (World, 1980) recognises a distinction between a 
problem or illness, and it’s consequences. The consequences are classified as 
impairments (loss of function), disability (restriction or lack of ability to perform an 
activity in the manner or within the range considered normal for a human being) and 
handicap (disadvantage which limits the fulfilment of role).  
 
In light of the above discussion it is important that measurement of outcome be multi-
dimensional, covering not only alcohol and drug use quantity and frequency but also 
symptoms and disability or functioning (including psychological, physical health) as 
well as risk to self and others. Only in this way can treatment efficacy be 
comprehensively defined. 
 
How do we measure these outcome domains once they have been identified? How can 
the outcomes of treatment services be measured effectively and consistently and 
compared across services, sites and service areas? Standardised measures are the most 
appropriate measures to achieve this end. 
 
Standardised measures are those that have been proven to test the target domain, that 
have been shown to provide consistent results both over time and when administered 
by different raters, and those that are simple to administer and have easily 
interpretable results.    
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Why use standardised measures of outcome? 
 
Clinicians use their clinical impressions as the main tool to continuously monitor and 
evaluate the outcome of their treatment for each client. Similarly, consumers are 
usually aware of their own well-being. This informal assessment of outcome should 
guide clinicians towards desirable treatments and away from ineffectual ones. The 
argument is, therefore, not "why measure outcome" for everyone does at some level, 
but "why attempt to introduce standardised measures of outcome". The problem is 
that while clinical judgements are important and necessary, they have repeatedly been 
shown to be unreliable (Meehl, 1954).  
 
Global judgments are equally fallible simply because they are dominated by the 
clinician's recent experience of patients who they wrongly believe to be representative 
of all patients (Cohen & Cohen, 1984). In reality the patients who are seen most often 
are those who are slow to improve, whilst assessment of an entire patient group might 
generally reveal good outcomes (Andrews et al., 1994).  
 
Having accurate information about outcome is therefore important to good clinical 
care. Standardising the content and the scoring of outcome measures ensures their 
validity and comparability across services and settings. Obtaining standardised 
responses to standardised questions is an efficient way to measure health, in part 
because results from many different studies and locations can be collated when 
standardised measures are used. The repeated measurement of symptoms, disability 
and risk factors using standardised measures is likely to improve treatment as well as 
provide the information necessary for identifying the outcome of treatment. 
 
Routine outcome measurement requires a commitment of resources and infrastructure 
if it is to be accomplished. This review is being conducted in conjunction with the 
development of a clinical monitoring system for alcohol and other drug services. This 
system provides the input and process data context of the outcome measurement. 
Such infrastructure along with a commitment of staff resources is a necessity in the 
application of routine outcome measurement.   
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Characteristics of good measures 
 
The importance of using standardised instruments to measure outcome should be 
clear. What is it then that separates a good standardised measure from a poorer 
measure? Basically, a good measure is one that has high levels of internal 
consistency, test-retest reliability and, where applicable, inter-rater reliability. A good 
measure should also have high content, construct and criterion validity. Replication 
studies demonstrating the psychometric properties of an instrument are important in 
order to further validate the findings. Finally in terms of the practical application of an 
outcome measure in the drug and alcohol field, a good measure is one that is brief and 
requires minimal training.  
 
Internal consistency 
 
High internal consistency means that the test scales correlate highly with each other 
and thereby measure a single phenomenon. The most stringent measure of internal 
consistency is Cronbach's Alpha (Cronbach, 1951). Coefficient alpha ranges from 0, 
indicating that the scale is not at all consistent, to 1, indicating perfect consistency. 
Acceptable levels of consistency tend to range from 0.8 to 0.95. Shorter scales tend to 
have lower levels of internal consistency. 
 
Test-retest reliability 
 
Test-retest reliability means that the test results for any given individual are quite 
consistent over 2 separate administrations of the test by the same clinician/worker, in 
a short time period (to exclude differences due to changes in the individuals health as 
a function of time or treatment). The most stringent form of test-retest reliability is the 
intra-class correlation coefficient. Values of 0.81-1.00 are considered to be close to 
perfect, 0.61-0.80 substantial, 0.41-0.60 moderate, and 0.21-0.40 fair and below 0.2 
indicative of a very small relationship (Landis & Koch, 1977).  
 
 
Inter-rater reliability 
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This refers to the ability of an instrument to produce the same or a very similar result 
when two different people administer the instrument to the same client. If the scores 
for an individual on the same instrument tested by different clinicians over a very 
short time period are quite similar, then the instrument is said to have high inter-rater 
reliability. Cohen’s Kappa coefficient is the statistic most often used to demonstrate 
the level of inter-rater reliability (Cohen, 1960). Kappa values of 0.40 and above, are 
considered acceptable. The closer to 1.00 the Kappa, the higher is the test-retest 
reliability. 
 
Content Validity 
 
Content validity refers to the ability of the instrument to adequately cover the domain 
that it purports to measure. Content validity is the basic building block on which the 
instrument is established. Content validity is also sometimes referred to as face 
validity; the degree to which an instrument appears to be sampling the area it is 
designed to measure. 
 
Construct Validity 
 
Construct validity is the extent to which an instrument is able to adequately measure 
the underlying construct such as health, depression, quality of life or intelligence. 
Construct validity is usually demonstrated by comparing the instrument to other 
standardised instruments with proven psychometric properties. The instrument should 
correlate highly with very similar instruments (convergent validity), moderately with 
somewhat similar instruments, and not at all with instruments that have been proven 
to measure totally different constructs (divergent validity). 
 
Criterion validity 
 
Criterion validity refers to the ability of an instrument to predict scores on direct 
external criteria of which the test purports to measure. For example, an instrument 
used to test physical ill health would be expected to correlate highly with days sick 
from work, visits to a GP and blood tests. An instrument used to test for alcohol abuse 
would be expected to correlate highly with poor results from a liver function test. 
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Sensitivity to change 
 
This refers to the ability of the instrument to reflect real changes in the external 
criteria of a client. For example, if a client is tested before and after treatment, the 
score of the client on an instrument that measures physical ill-health should be lower 
the second time the client is tested, if physical examination reveals marked 
improvement following treatment. The change in the client's score on this instrument 
should also be consistent with changes in other related criteria such as days absent 
from work. 
 
Practicality of the instrument 
 
If an instrument is to be used in routine clinical assessment then it must also be brief, 
easy to understand and administer. It must also be simple to score and have easily 
interpretable results (Slade, Thornicroft, & Glover, 1999). 
 
Professional versus self rated questionnaires and interview  
 
There is also the issue of internal validity or the extent to which the information 
collected is a true reflection of the facts. Self report by clients with an alcohol or other 
drug problem has often been found to be inaccurate. The reasons for this include 
individual differences in recall ability, fear of legal complications associated with 
disclosure of illicit drug use, demand characteristics (wanting to please the 
researcher/clinician), and emotional factors that distort accurate recall. 
 
Clinician rated questionnaires and interviews are considered to be slightly more 
accurate as they can be more objective, however there is also unintentional bias that 
can come from the clinician in both questionnaires and interviews. Third party 
assessment of change is therefore often beneficial as it can eliminate clinician bias. 
Structured interviews whilst providing more comprehensive information on clients are 
often longer and thus more costly and generally burdensome. 
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As discussed above a questionnaire which meets the criteria for standardisation, is 
clinician rated and brief in order to avoid the burdens of time and cost is possibly the 
most suitable type of instrument for routine outcome measurement.  
   
When to measure? 
 
Now that the most effective way of measuring change have been established, it is 
important to discuss at what points measurement need take place in order to improve 
sensitivity to change. There is no standard rule about the timing of measurement. If 
measurement is being used to inform the clinician about client progress then 
measurement is necessary at the beginning, throughout, and at the end of treatment. 
Gathering a consistent baseline is important with this type of single subject approach, 
and measurements should be no longer than 6 months apart. Measurement at the 
beginning and end can be sufficient to gauge overall outcome of a treatment and is 
particularly enhanced if data can be compared to changes achieved in a normative 
sample.   Finally, longer-term follow-up can be very useful to ascertain the 
sustainable benefits from a particular treatment.  (Andrews et al., 1994). 
 
It should be noted that there are particular difficulties associated with the process of 
following up clients who have utilised alcohol and other drug services.  Frequent 
changes in residency, fears associated with the illicit nature of some substance use, 
criminality and incarceration as well as death from overdose, are all factors that can 
interfere with comprehensive follow up in this population (Cottler, Compton, Arbi, 
Horne, & Claverie, 1996). Follow up at both three and six-month intervals are 
therefore important in this group, as clients may be slightly more accessible in the 
shorter term.  
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METHOD 
 
Consultation 
 
A brief survey was conducted of 58 government and non-government alcohol and 
other drug treatment services. These agencies were chosen from mailing lists at the 
National Drug and Alcohol Research Centre. In this pilot 58 surveys were mailed, 42 
were received completed, 6 were returned blank due to incorrect addressing and 10 
were not returned. This represents a response rate of 72%. 
 
Three main questions were covered: importance of measurement of different areas of 
drug and alcohol treatment outcome, importance of methods of assessment, and the 
uses of outcome measurement. Importance is rated on a 5 point scale from "1" (not 
important) to "5" (extremely important). The main areas in which consumer outcome 
can be measured are included in the questionnaire, namely symptoms, disablement or 
functioning, quality of life, and satisfaction with services. An "other" option was also 
provided to allow respondents to nominate other areas of importance. 
 
Five assessment formats were rated covering questionnaires completed by the 
consumer, clinician, or family member, an interview with the consumer, and a rating 
scale completed by the clinician. A range of ‘uses of information obtained from 
outcome measurement’ were also assessed and include: to inform the clinician about 
progress of the consumer, to inform the consumer about their own progress, to assess 
the efficacy of treatment services, to make funding decisions about services, and an 
"other" option.  
 
Literature 
 
A thorough search of the literature was conducted in order to identify all of the 
outcome measures that have been used both in the mental health and alcohol and other 
drug field. This was achieved by searching the Medline, Psych Info, Embase and Web 
of Science databases. A general Internet World Wide Web ‘Excite’ search was also 
conducted. The substance abuse treatment literature and associated citation lists were 
then examined to ensure that those instruments whose name is not included in the title 
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or abstract of the published article (the basis on which web searches operate) were not 
omitted. Further outcome measures were identified through this process. Only those 
measures used with the alcohol and other drug population were considered. 
   18
   
RESULTS 
 
Consultation 
 
The results are presented in Table 1 below.  Consultation with the field demonstrated 
that use of alcohol and other drugs (quantity/frequency) and functioning were 
considered to be the most important areas of outcome evaluation.  ‘Clinician rated 
questionnaire’ or ‘interview with the client’ were rated as the preferred methods and 
respondents stated that the collection of such data would improve the effectiveness of 
treatment. Those denoted with an asterisk were rated significantly different to other 
ratings (p<0.05).  
 
Table 1. Survey of attitudes to outcome measurement. 
Survey Question Mean Median SD 
Area    
Use Drugs or alcohol 4.5* 5 0.7 
Disability/functioning 4.4* 4 0.6 
Quality of life 4.1 4 0.8 
Satisfaction 3.7 4 0.8 
Physical/psychological 4.3 4 0.6 
Health    
Method    
Questionnaire for consumers 4.1* 4 0.8 
Questionnaire for clinician 3.7 4 0.9 
Questionnaire for family 3.0 3 0.9 
Interview with consumer 4.0* 4 1.0 
Rating by Clinician 3.9 4 0.9 
Uses    
Inform clinician 4.2 4 0.7 
Inform Consumer 4.1 4 0.9 
Service efficacy 4.5* 5 0.6 
Service funding 3.7 4 1.0 
Rating scale; 1=not at all important; 2 = a little important; 3 = somewhat important; 4 
= very important; 5 = extremely important 
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Literature search 
 
Initially the literature search methods yielded a list of almost 300 instruments. The 
full list can be found in appendix A. 
 
Once this final list was assembled it was then necessary to eliminate all of those 
instruments that were too specific to be considered as overall outcome measures. 
Instruments such as those that detect biochemical markers, instruments that assess 
‘craving’ or ‘moods’ or ‘latency to relapse’ or ‘high-risk situations’ exclusively were 
eliminated. This decision was made on the basis that such specific measures are too 
narrow to be used as an outcome assessment.  
 
Further elimination of instruments was made on the basis of insufficient published 
information. Measures that were cited only once in the literature, or measures that 
have been used infrequently, or not used for many years, were also eliminated from 
detailed examination. 
 
As a result of this process, 44 instruments remained. These instruments were then 
examined in detail by collecting the relevant articles that document testing of their 
psychometric properties. At least two of the authors then rated all instruments 
independently. Where any discrepancy arose, each examiner discussed their rationale 
for their rating of the instrument until consensus was achieved.  
 
The rating criteria for the instruments can be found in the appendix and are as 
follows: - for each category of reliability; item, test-retest and inter-rater and for each 
category of validity; content, construct and criterion the measure could receive a 
rating of either 1 weak, 2 adequate or 3 excellent. A summary rating was also given 
on the same scale depending on the rating for each category, and the number of 
studies reporting on the psychometric findings. For example a measure that has high 
levels of each type of reliability and validity but only a few reported studies on the 
psychometrics was given an adequate overall rating. A measure that has adequate 
levels of reliability and validity reported in numerous studies was also given an 
adequate rating and an instrument that has adequate ratings of some measures of 
reliability and validity in few studies was rated as weak. 
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The 44 instruments fall into the following categories: ‘screening for problematic use 
and quantity/frequency’, ‘diagnosis of dependence/harmful use’, ‘functioning’, 
‘multi-dimensional measures’, ‘relapse’, and ‘satisfaction with service’. 
 
Screening for problematic use/ quantity/frequency 
 
Screening instruments are those that are used to detect potentially harmful levels of 
alcohol or other drug use. They are generally brief, easily understood by the client and 
easily scored by the clinician (Dawe & Mattick, 1997). They need to provide reliable 
information that alerts the clinician to the need, or lack thereof, for further assessment 
and treatment. The literature search uncovered nine instruments that fall into this 
category. They are outlined in Table 2.  
 
The following instruments comprise this list; The Alcohol Use Disorder Identification 
Test (Audit) (Saunders, Aasland, Babor, Fuente, & al., 1993), the Alcohol Use 
Inventory (Horn, Wanberg, & Foster, 1974), The CAGE (Ewing, 1984), The 
Customary Drinking & Drug Use Record (Brown et al., 1998), The Drug Use 
Screening Inventory (Tarter & Hegedus, 1991), the Form 90 (Miller & Del Boca, 
1994), the Michigan Alcoholism Screening Test (Selzer, 1971), the Time Line Follow 
Back (Sobell & Sobell, 1992), and the TWEAK (Russell, 1994). 
 
Most of these instruments were designed as brief tools to detect potentially harmful 
alcohol or other drug use and as such are not comprehensive enough to be used as a 
measure of treatment outcome. Most have not been tested for their sensitivity to 
change over time and some have very little psychometric testing reported in the 
literature. For all of these reasons none of these instruments can be considered for use 
as a routine outcome assessment tool. 
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Table 2. Screening/Assessment Instruments 
 
 
TITLE & AUTHOR & 
ORIGIN/SOURCE 
 
 
TIME 
Mins 
 
DESCRIPTION 
 
VALIDITY 
 
RELIABILITY 
 
SENSITIVITY 
Alcohol Use Disorder Identification Test: AUDIT 
1993 (Saunders,  Centre for Drug & Alcohol Studies 
Camperdown, Australia) 
 
5 10 items; past 12 months 
Assesses harmful/hazardous drinking, forced 
choice, max score 40, cut off score id’s pathology 
Self or clinician rated questionnaire 
Free, nil  training, 400 citations 
 
Content adequate 
Construct adequate 
Criterion adequate 
Item adequate 
Test-retest adequate 
Yes 
Alcohol Use Inventory 1974 
(Horn, Centre for Alcohol Abuse, Research & Eval, Denver, 
Colorado, USA) 
35-60 147 items; 16 primary scales covering styles of 
use, unfavourable consequences & benefits of 
drinking 
Self rated questionnaire, training required, 20 
citations, $29.50 + $13.50 per test 
Construct adequate Item adequate Unknown 
CAGE 1994 
(Ewing, , JAMA,252 1905-1907) 
5 4 items; past/present 
Covering need to Cut down, Annoyed at criticism 
re drinking, Guilty about drinking, need for Eye 
opener to remove hang over. Nil training, 1500 
citations, Clinician rated. Free 
Content adequate 
Criterion adequate 
Item adequate Yes 
Customary Drinking & Drug Use Record (CDDR) 1987 
(Brown , Psychol Ser, Veterans Affairs Med Ctr, California, 
USA) 
15-30 3 months past & lifetime. Use quantity 
&frequency, psychological/behavioural 
dependence, withdrawal, consequences. Training 
required, 3 citations 
Clinician rated questionnaire 
Content adequate 
Construct adequate 
Criterion adequate 
Item adequate 
Test-retest adequate 
Inter-rater adequate 
Unknown 
Drug Use Screening Inventory-Revised (DUSI-R) 
1990 
(Tarter et al, Gordion Grp, Hartsville, SC, USA) 
15-20 159 items past yr, month week10 domains- AOD 
Use, Behaviour, Health, Psych disorder, Social, 
Family, School, Work, Peer & Leisure 
nil training, 10 citations 
Clinician or self rated questionnaire 
Content adequate 
Criterion adequate 
Item adequate 
Test-retest adequate 
Inter-rater adequate 
Unknown 
Form 90 1993 
(Miller, Dep Psychol, Uni New Mexico, Alberquerque, USA) 
40-60 90 items, past 90 days 
Calender used to chart consumption. BAC peaks 
also calculated, 2 days training, 53 citations 
Clinician rated interview 
Content adequate 
Construct adequate 
Test-retest adequate 
Inter-rater adequate 
Unknown 
 
Michigan Alcoholism Screening Test MAST  1971 
(Selzer, Dep Psychiatry, Uni Michigan, Ann Arbor, Michigan)  
10-15 25 items, current, past 
assessing problematic alcohol use 
forced choice Y/N answers, nil training, 190 
citations 
Self or clinician rated questionnaire 
Content adequate 
Construct adequate 
Criterion adequate 
 
Item adequate 
Test-retest adequate 
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Table 2. Screening/Assessment Instruments cont’d……… 
 
 
 
TITLE & AUTHOR & 
ORIGIN/SOURCE 
 
 
TIME 
Mins 
 
DESCRIPTION 
 
VALIDITY 
 
RELIABILITY 
 
SENSITIVITY 
Time Line Follow Back (TLFB)1985 
(Sobell, NIAA Treatment Handbook, DHHS pub No 85 1380) 
5 30-60 items, past 30-60 days 
estimates quantity/frequency using calender + 
memory aids, nil training, 7 citations 
Self rated record. Free 
Content weak 
Construct adequate 
Criterion adequate 
Test-retest adequate Unknown 
 
TWEAK 1979 
(Russell  1994, Alcohol health & Research World, 18:1, 55-
61) 
5 5 items current 
Assessing risk; Tolerance, others Worried about 
your drinking, need for Eye opener, Amnesia 
(memory loss of drinking episode), need to C 
(K)ut down. Max score 7. Cut off defines risk, Nil 
training, 25 citations 
Self or clinician rated questionnaire. Free 
Construct adequate 
Criterion Adequate 
Unknown  Unknown
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Diagnosis (Dependence/Harmful use) 
 
Diagnostic instruments are those that can identify that an individual has a clinical 
alcohol or other drug syndrome (Dawe et al, 1997). Diagnostic instruments are longer 
and more comprehensive than screening instruments. Diagnostic instruments allow an 
individual’s condition to be classified according to specific and widely recognised 
criteria (Such as DSM IV or ICD-10). They can provide an indication about suitable 
treatments/management plans for that individual. (They do not provide information on 
specific features of each individual case, and cannot substitute for a comprehensive 
collection of all information pertinent to each individual’s presenting problems). 
 
The literature search yielded a total of fifteen instruments that meet the 
standardisation criteria and fit into this category. These can be found in table 3 below. 
The CIDI-SAM (Cottler, Robins, & Helzer, 1989), the Adolescent Drug Abuse 
Diagnosis (Friedman & Utada, 1989), the Alcohol dependence Scale (Skinner & 
Allen, 1982), the Benzodiazepine Dependence Questionnaire (Baillie & Mattick, 
1996), the Comprehensive Addiction Severity Index (Myers, McLellan, Jaeger, & 
Pettinati, 1995), the Dartmouth Assessment of Lifestyle (Rosenberg et al., 1998), the 
Fagerstrom Test for Nicotine Dependence (Heatherington, Kozlowski, Frecker, & 
Fagerstrom, 1991), the Leeds Dependence Questionnaire (Raistrick et al., 1994), the 
MacAndrew Alcoholism Scale (MacAndrew, 1965), the Millon Clinical Multiaxial 
Inventory (Craig, 1999), the Severity of Alcohol Dependence Scale (Gossop et al., 
1995), the Severity of Opiate Dependence Scale (Sutherland et al., 1986), the Short 
Form Alcohol Dependence Data Questionnaire (Raistrick, Dunbar, & Davidson, 
1983), and the Substance Abuse Treatment Scale (McHugo, Drake, Burton, & 
Ackerson, 1995) are all included in the following table. The sensitivity to change of 
most of these instruments has not been documented in the literature and most of these 
instruments are too long to be considered as a routine outcome assessment tool.  
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Table 3. Diagnosis 
 
 
TITLE & AUTHOR & 
ORIGIN/SOURCE 
 
 
TIME 
Mins 
 
DESCRIPTION 
 
VALIDITY 
 
RELIABILITY 
 
SENSITIVITY 
Adolescent Drug Abuse  
Diagnosis (ADAD)1989 
(Friedman, Belmont Ctr for Comprehensive treat, 
Philadelphia, USA) 
45-60 150 items.  9 areas; medical, school, employment, social, 
family, psychological, legal, alcohol, drug. Composite scores 
& severity ratings 
Clinician administered interview .Questionnaire free, $10-$90 
manual, software etc, 1 day training, 2 citations 
Content adequate 
Construct adequate 
Criterion adequate 
Item adequate 
Test-retest 
adequate 
Inter-rater 
adequate 
Unknown 
Alcohol Dependence Scale 
(Skinner & Allen; addiction Research foundation, 
Toronto, Canada) 
15  25 items; past 12 months 
Assesses physical dependence, forced choice responses  
Self rated questionnaire users guide $18.00, 0.40c per 
questionnaire, Nil training, 80 citations 
Content adequate 
Construct adequate 
Criterion adequate 
 
Item 
Execellent 
Test-retest 
adequate 
Unknown 
Benzodiazepine Dependence Questionnaire 
BDEPQ)1996 
(Baillie , Dep Psychol, Macquarie Uni, Ryde, NSW, 
Australia) 
5-10 30 items, 4pt likert scale 
sub scales- gen dependence, pleasant effects & perceived need, 
nil training, 5 citations 
Content adequate 
Construct adequate 
Criterion adequate 
Item adequate 
Test-retest 
adequate 
Unknown 
Composite International diagnostic Interview-
Substance Abuse Module (CIDI-SAM)  1997 
(Cottler, Dep Psych, Washington Uni School 
medicine, St Louis, USA) 
60 276 items, lifetime or recent period  
eg past month/year 
1 week training, 180 citations 
Clinician rated interview  
Content adequate 
Construct adequate 
 
Test-retest high 
Inter-rater high 
Unknown 
Comprehensive Addiction Severity index (CASI-
A) 1995 
(Myers , University of Pennsylvania, VA Medical 
Ctr, Pennsylvania, USA) 
45-60 Assesses known risk factors, concomitant symptomatology, + 
AOD consequences in 7 domains,  
Training required, 3 citations 
Clinician rated interview 
Content adequate 
Construct adequate 
Criterion adequate 
Item adequate Unknown 
Dartmouth Assessment of Lifestyle Instrument( 
DALI) 
1998 (Rosenburg, Dep Psych, Dartmouth College, 
New Hampshire, USA)  
5-10 18 items,  Current 
Assesses alcohol &/or Drug us disorder, 2 scales – alcohol, 
drug, nil training, 1 citation 
Clinician rated interview, Free 
Content adequate 
Criterion adequate 
Test-retest 
adequate 
Inter-rated 
adequate 
Unknown 
Fagerstrom Test of Nicotine Dependence (FTND) 
1991 
(Fagerstrom, Smoking Wdl Clin, Ulleraker Hospital, 
Sweden) 
5-10 6-8 questions, overall score indicates minimal, moderate or 
severe dependence 
Free. self or clinician rated, nil training 
Content adequate 
Construct adequate 
Criterion adequate 
Item adequate 
Test-retest 
excellent 
Unknown 
Leeds Dependence Questionnaire (LDQ) 1994 
(Raistrick, Leeds Addiction Unit, Leeds, UK) 
5-10 10 items, preceding week 
Salience, compulsion to start, & continue, planning, max 
effect, narrowing repertoire, primacy of effect, consist of state, 
cog set. Free 1 hr training, 3 citations, Self rated questionnaire 
Content adequate 
Construct adequate 
Item adequate 
Test-retest 
adequate 
Unknown 
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Table 3. Diagnosis cont’d…….. 
 
 
TITLE & AUTHOR & 
ORIGIN/SOURCE 
 
 
TIME 
Mins 
 
DESCRIPTION 
 
VALIDITY 
 
RELIABILITY 
 
SENSITIVITY 
MacAndrew Alcoholism Scale 1965 
(MacAndrew, 1965, Quarterly Journal of  Studies on 
Alcohol, 26:2, 238-46) 
30-90 49 items form MMPI, current 
determining diagnosis, prognosis & personality factors, 
forced choice T/F response format 
nil training, 90 citations 
Self rated questionnaire. $1.00 per test 
Content weak 
Construct weak 
Criterion weak 
Test-retest 
adequate 
Unknown 
Millon Clinical Multiaxial Inventory (MCMI) 1983 
(Millon, National Computer Systs  Inc, Minneapolis, 
USA)  
20-25 175 items,26 sub-scales 
Nil training, 71 citations 
Clinician or self rated questionnaire 
$0.25 per Questionnaire, $20 scoring & interpretation. 
Content adequate 
Construct adequate 
Criterion adequate 
 
Item adequate 
Inter-rater 
adequate 
Unknown 
Severity of Alcohol Dependence Questionnaire SADQ 
1979 
(Stockwell, Curtin Uni of Tech, Curtin WA, Australia) 
5-10 20-33 items,  past 6 months 
5 domains; physical, affective, need (craving), quantity, 
post abstinence rapidity of reinstatement of symptoms, 
forced choice- never to nearly always. Nil training, 40 
citations. Self or clinician rated questionnaire 
Content adequate 
Construct adequate 
Criterion adequate 
Item adequate 
Test-retest 
adequate 
Unknown 
 
 
 
 
Severity of Dependence Scale (SDS) 1995 
(Gossip, National Addiction Centre, Maudsley Hospital, 
London, UK) 
5 5 items, past year 
Loss of control of use, worry re missed dose, worry re use,  
desire to stop,  difficulty  stopping/ missing dose. Nil 
training, 13 citations 
Self rated questionnaire 
Content adequate 
Construct adequate 
Criterion adequate 
Item adequate 
Test-retest 
adequate 
Yes 
Severity of Opiate Dependence Questionnaire (SODQ) 
1986 
(Sutherland, Addiction Res Unit, Inst Psychiatry, London) 
10 21 items, most recent 1 month of heavy use 
Qty & pattern opiate use, phys wdl sympt, affect wdl 
sympt, wdl relief drug taking, rapidity of reinstat of sympt 
post abstinence, nil training, 5 citations 
Content adequate 
Construct adequate 
Criterion adequate 
Item adequate  
Short Form Dependence Data Questionnaire SADD 
1983 
(Raistrick, Leeds Addiction Unit, Leeds, UK) 
5 15 items, Recent 
Assesses dependence; physical, psychological/emotional & 
behavioural. Forced choice 4 pt scale never to nearly 
always. Nil training, 4 citations 
Self rated questionnaire. Free 
Content adequate 
Construct adequate 
Criterion adequate 
Item adequate 
Test-retest 
adequate 
Unknown 
Substance Abuse Treatment Scale (SATS) 1990  
(McHugo, Dartmouth Psych Res Centre, New Hampshire, 
USA) 
5 Assesses stage of change, past 6 months 
Clinician rated scale 
Nil training, 21 citations 
Content adequate 
Construct adequate 
Criterion adequate 
Test-retest 
adequate 
Inter-rater 
adequate 
Unknown 
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Relapse 
 
Relapse questionnaires are those that detect the degree of risk of an individual of 
returning to a potentially dangerous or harmful level of alcohol or other drug use. 
Relapse questionnaires are generally brief and provide clients and clinicians with an 
indication of the areas that need addressing if abstinence is to be maintained. The 
literature search yielded 4 such measures; The Abstinence Self-Efficacy Scale 
(DiClemente, Carbonari, Montgomery, & Hughs, 1994), the Cocaine Relapse 
Interview (McKay, Rutherford, Alterman, & Cacciola, 1996), the Controlled Drinking 
Situational Confidence questionnaire (Sitharthan & Kavanagh, 1990), and the 
Situational Confidence questionnaire (Anis, 1982). These can be found in table 4. 
 
All of the questionnaires in this category assess a particular aspect of an alcohol or 
drug problem. All have unknown sensitivity to change and most have not been well 
cited in the literature. For all of these reasons none of these instruments would be 
suitable as a routine outcome measurement tool. 
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Table 4. Relapse Measures 
 
 
TITLE & AUTHOR & 
ORIGIN/SOURCE 
 
 
TIME 
Mins 
 
DESCRIPTION 
 
VALIDITY 
 
RELIABILITY 
 
SENSITIVITY 
Alcohol Abstinence Self Efficacy Scale 
1993 (DiClemente,  Dep Psych, Uni Houston, USA) 
10  20 items; Current time 
Assesses belief in ability to resist urge to drink heavily 
(alcohol). Negative affect, social positive, physical & other 
concerns, withdrawal & urges. Nil  training, 4 citations, 
Self  rated questionnaire 
Content adequate 
Construct adequate 
Criterion adequate 
Item 
Adequate 
Unknown 
Cocaine Relapse Interview (CRI) 1996 
(McKay, Uni Pennsylvania, Trt Res Ctr, Philadelphia, 
USA) 
30 5 categories, Experiences on day prior to relapse, 
experiences in week prior to R, attributions re cause of 
relapse, experiences post onset, perceptions re factors assoc 
with termination of relapse, training- unknown, 5 citations 
Criterion adequate Item adequate 
Test-retest adequate 
Unknown 
Controlled Drinking Situational Confidence 
Questionnaire 1991 (Sitharthan, Drug & Alc Dep, RPA 
Hospital, Camperdown 2050, Australia)   
?? 16 items, current/future 
Assesses confidence in not drinking heavily in 16 high risk 
situations (0-100% ratings)- 2 scores; self efficacy strength 
(overall confidence) & self efficacy level (No. situations 
with max confidence) 
Training unknown, 1 citation, Clinician rated  
Criterion moderate Unknown Unknown 
Situational Confidence Questionnaire 1982 
(Annis, Addiction Research Foundation, Toronto Canada) 
15 39 items, current 
assesses confidence in ability to resist drinking; profile in 2 
areas- 1/personal states 2/social situations, $25 (25 
questionnaires & manual- additional cost for software), 
users guide for  training, 18 citations. Self rated 
questionnaire 
Content adequate 
Construct adequate 
Criterion adequate 
Item adequate Unknown 
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Functioning 
 
Instruments that assess level of functioning are those that provide a profile of how 
well an individual is able meet the challenges of everyday living. These instruments 
generally cover the domains such as a) psychological functioning – eg levels of mood, 
anxiety/depression, b) social functioning- ability to maintain relationships with others, 
c) physical functioning – ability to attend to self hygiene, motivation/energy levels  
and/or d) behaviour – level of violence/aggression. Instruments that fall into this 
category can be found in the table 5. 
 
The Global Assessment Scale (Endicott, Spitzer, Fleiss, & Cohen, 1976), the General 
Health Questionnaire (Goldberg, 1972), the Nottingham Health Profile (Hunt, 
McKenna, McEwen, Williams, & Papp, 1981), the Short Form 36  (Ware & 
Sherbourne, 1992), and the Symptom Checklist 90 Revised (Derogatis, 1983) all fall 
into this category. All of these instruments have good levels of reliability, validity and 
sensitivity to change but none have a component that measures quantity or frequency 
of alcohol or other drug use. For this reason none of these instruments except the SF 
36 were selected for potential use as a routine outcome assessment tool. The SF 36 
was considered because of its strong psychometric properties and its considerable use 
as an outcome tool. 
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Table 5. Functioning 
 
 
TITLE & AUTHOR & 
ORIGIN/SOURCE 
 
 
TIME 
Mins 
 
DESCRIPTION 
 
VALIDITY 
 
RELIABILITY 
 
SENSITIVITY 
General Health Questionnaire (GHQ) 1972  
(Goldberg, General Practise Res Unit, De Crespigny Pk, 
London, UK) 
5-15 12,  20,  28, 30 or 60 items, Current 
4 area; depression, anxiety, behaviour, 
hypochondriasis, 4 pt likert scale 
Nil training, 1625 citations 
Self rated questionnaire  
Content high 
Construct high 
Criterion adequate 
Item high 
Test-retest adequate 
Yes 
Global Assessment Scale (GAS) 1976 
(Endicott, NY State Psych Inst, NY, USA) 
5-10 1 item, Current 
Rating 1-100, 10 equal intervals from 1-10  
(needs constant supervision) to 90-100 (superior 
functioning in wide range activities). Appropriate 
category chosen 
6 hrs training, 197 citations, Clinician rating 
Content adequate 
Construct adequate 
Criterion adequate 
Inter-rater adequate Yes 
Nottingham Health Profile (NHP) 1981 
(Hunt, Dep Comm Hlth, Queens Med Ctre, Uni Nottingham, 
UK) 
10 38 items, Current 
6 dimensions; energy, emotional reaction, social 
isolation, sleep, pain, phys mobility Y/N answers 
nil training, 333 citations 
Self rated questionnaire 
Content high 
Construct adequate 
Criterion adequate 
Test-retest adequate Yes 
 
 Short Form 36, SF-36 
(Ware & Sherbourne, The health Inst, Boston, USA) 
5-10 8 variables- gen health, mental health, pain, phys 
functioning, role limitations physical, role 
limitations emotional, vitality, social functioning, 
self or clinician rated questionnaire. Nil training, 
no charge 
Content excellent 
Construct excellent 
Criterion  adequate 
Item adequate 
Test-retest excellent 
Inter-rater excellent 
Yes 
Symptom checklist 90 Revised (SCL90- R) 1973 
(Derogatis, Clinical Psychometrics Res Inc, Maryland, USA) 
10-20 90 items,  Current 
9 areas; Somatisation, OCD, anxiety, hostility, 
phobic anxiety, paranoid ideation, psychoticism, 
5 pt likert scale, gen symptom index. Nil training, 
10 citations 
Self rated questionnaire   
Content adequate 
Construct adequate 
Criterion adequate 
Test-retest adequate Yes 
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Satisfaction with Service 
 
Questionnaires that assess satisfaction with services are those that provide information 
about the degree to which individual recipients of treatment (clients) feel that the 
treatment they received was satisfactory/beneficial. These questionnaires cover the 
domains of both the physical environment in which the service was provided as well 
as the quality of care from the staff who delivered the service. The literature search 
yielded a total of three such instruments (refer Table 6). 
 
The Client Satisfaction Questionnaire (Attkisson & Zwick, 1983), the Service 
Satisfaction Scale (Greenfield & Attkisson, 1989) and the Verona Service Satisfaction 
(Ruggeri & Dall'Agnola, 1993) all fall into the category of satisfaction with service. 
These questionnaires reflect information about the clients’ feelings regarding the 
service they have received. Satisfaction with service has not been shown to be 
consistently related to outcome (Andrews et al., 1994); a client may be thrilled with 
the level of care they received but their level of functioning may not necessarily 
benefit from such care. Consequently these instruments cannot be used as routine 
outcome assessments. 
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Table 6. Satisfaction questionnaires  
 
 
TITLE & AUTHOR & 
ORIGIN/SOURCE 
 
 
TIME 
Mins 
 
DESCRIPTION 
 
VALIDITY 
 
RELIABILITY 
 
SENSITIVITY 
Client Satisfaction Questionnaire 1982 
Attkisson & Zwick 
10 31 items covering 9 categories: physical 
surrounding, support staff, types of service, 
treatment staff, quality of service, outcome of 
service, general satisfaction, procedures. 
Clinician or self rated, 50c each. 
Content adequate 
Construct adequate 
Item adequate No 
 
 
Service Satisfaction Scale 1989 
Greenfield & Attkisson 
10 30 items covering interpersonal manner, technical 
quality, efficacy/outcomes, 
accessibility/convenience, finances, physical 
environment, availability, self rated over 1 year, 5 
pt scale, nil training, cost ?? 
Content adequate 
Construct adequate 
Item adequate No 
Verona Service Satisfaction Scale-Patients 1993 
Ruggeri & Dall’Agnola 
45 56 items covering 7 areas: overall satisfaction, 
skills & behaviour, information, access, efficacy, 
types of intervention, relatives involvement. 5-pt 
scale, self or clinician rated, 2 days training, cost 
??? 
Content adequate 
Criterion 
forthcoming 
Test-retest adequate No 
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Multi-dimensional 
 
Questionnaires and interviews that fall into this category gather information across a 
number of domains. These instruments generally provide information on all or most 
of the following: the level of alcohol and/or drug use, physical functioning, 
psychological functioning, social functioning, leisure activities, behaviour, and 
satisfaction with service. The literature search identified seven instruments that can be 
classified as multi-dimensional. These can be found in the Table 7. 
 
The Addiction Severity Index (McLellan et al., 1992), the Alcohol Problems 
Questionnaire (Drummond, 1990), the Drug Use Screening Inventory (Tarter & 
Hegedus, 1991), the Health of the Nation Outcomes Scales (Wing et al., 1998), the 
Opiate Treatment Index (Darke, Hall, Heather, Wodak, & Ward, 1992), the Teen 
Addiction Severity Index (T-ASI) (Kaminer, Bukstein, & Tarter, 1991), and the 
Treatment Outcome Profile (Holcomb, Parker, & Leong, 1997) have all been 
classified as multi-dimensional instruments.  
 
All of these instruments were examined in detail by the authors in order to determine 
which of these instruments would be most appropriate as a routine outcome 
assessment tool. 
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Table 7. Multi-dimensional 
 
TITLE & AUTHOR & 
ORIGIN/SOURCE 
 
 
TIME 
Mins 
 
DESCRIPTION 
 
VALIDITY 
 
RELIABILITY 
 
SENSITIVITY 
Addiction Severity Index (ASI) 
(McLellan, Penn VA Centre, Philadelphia USA) 
40-60 7 domains, substance abuse, medical, 
psychological, legal, family/social, employment, 
support, 
Clinician rated interview, training required, no 
charge 
Content adequate 
Construct Excellent 
Criterion Excellent 
Item excellent 
Test-Retest 
excellent 
Inter-rater excellent 
Yes 
Alcohol Problems Questionnaire 
1990 (Drummond, Addiction Research unit, London, UK) 
15-20 44 items, past 6 months 
8 problem domains; children, police, 
employment, finances, physical & psychological 
Self or clinician rated questionnaire, 6 citations 
Construct adequate 
Criterion adequate 
Item adequate 
Test-retest adequate 
Unknown 
Comprehensive Drinker Profile & Follow Up Profile 
1984 
(Miller & Marlatt, Psychol Assess Resources, Oddessa, Fl, 
USA) 
60-120 88 items, Lifetime 
Drinking History, motivation,, Demographic, self 
efficacy,20 hrs training, 5 citations 
Clinician rated interview, Approx $113, varies 
Content adequate 
Criterion adequate 
Test-retest adequate Unknown 
Drug Use Screening Inventory (DUSI) 1990 
(Gorney D, Gordion Group, PO Box 1587, Hartsville, SC 
29550) 
15-20 159 items, past week, month, year 
10 domains- AOD Use, Behaviour, Health, Psych 
disorder, Social, Family, School, Work, Peer & 
Leisure. Nil training, few citations. Clinician or 
self rated questionnaire 
Content adequate 
Criterion adequate 
Item adequate 
Test-retest adequate 
Inter-rater adequate 
Unknown 
Health of the Nation Outcome Scales (HoNOS) (Wing, 
Royal College of Psychiatrists, London, UK) 
15-30 12 scales- aggression, self harm, alcohol & drug, 
memory/orientation, physical problems, mood 
disturbances, hallucinations & delusions,  other 
mental problems, social relationships, social 
environment,  4 sub-scales behaviour, 
impairment, symptoms & social., clinician rated 
questionnaire, some training required, Free 
Content adequate 
Construct adequate 
Criterion adequate 
Item adequate 
Test-retest adequate 
Inter-rater adequate 
Yes 
Opiate Treatment Index (OTI) 
(Darke, National Drug & Alcohol Research Centre, Sydney 
Australia ) 
20-30 5 domains – AOD use, HIV risk behaviour, 
Criminal behaviour, Social and Psychological 
Functioning, Clinician rated interview, nil 
training. Free  
Content adequate 
Construct adequate 
Criterion adequate 
Item adequate 
Test-retest excellent 
Inter-rater adequate 
Yes 
Teen Addiction Severity Index (T-ASI) 1991 
(Kaminer, Uni Pittsburgh, School Med, Pittsburgh, PA, 
USA) 
30-45 Modelled on ASI, 7 domains, substance use, 
school performance, family, peer/social, 
employment, legal, psychiatric, training required, 
4 citations, Clinician rated interview. Free 
Content adequate 
Construct Adequate 
Criterion adequate 
Inter-rater adequate Unknown 
Treatment Outcome Profile (TOP) 1997 
(Holcomb, Dep Psych, Uni Missouri, USA) 
5-10 27 items, Current 
QOL, symptomatology, level of functioning & 
treatment satisfaction, forced choice 5 pt likert 
scale 
Manual for training, 3 citations. Self rated 
questionnaire 
Content adequate 
Construct adequate 
Criterion adequate 
Item adequate Unknown 
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Note that inclusion into the above tables is reflective only of the process and criteria 
used in this study to identify potential outcome measures for the purpose of 
widespread implementation.  
These criteria are that the instruments be  
• psychometrically sound (valid, reliable and sensitive to change),  
• practical,  
• used in the alcohol and other drug field and  
• that they are multi-dimensional – assessing different domains of AOD use and 
physical and emotional functioning. 
 
There are other measures that have been used with clients suffering from alcohol or 
drug use conditions that have not been included in the short list above. As outlined in 
the method, instruments assessing craving, withdrawal, biochemical evidence of AOD 
use, the existence of depression, anxiety or other mental health conditions are not 
listed above. None of these measures alone would be a satisfactory and generic 
indicator of treatment outcome and hence their exclusion from the above list. It may 
be necessary to use such specific measures in particular circumstances and with 
particular clients/studies. Instruments able to be used for these purposes can be found 
in the extended list of assessment measures located in the appendix 1.  
   
Of the multi-dimensional instruments, only three plus one instrument from the 
functioning category (the SF-36) met the stringent criteria used in this study, that is 
applicability, acceptability, practicality, reliability, validity, and sensitivity to change.  
Those four include the Addiction Severity Index, the Health of the Nation Outcome 
Scales, the Opiate Treatment Index and the Short Form 36-health survey. 
 
The Addiction Severity Index (ASI) 
 McLellan A, T., Luborsky, L., Woody, G, E., & O’Brien, C, P. (1980) 
 
The ASI was developed in 1980 to enable a group of clinical researchers in the United 
States to evaluate treatment outcome for people with substance abuse problems. This 
instrument is a structured interview consisting of seven scales; alcohol use, drug use, 
medical problems, psychological problems, family/social problems, employment 
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problems and legal problems. According to the ASI severity is defined as 'the need for 
additional treatment'. The interview takes approximately 45-60 minutes to administer 
by a trained professional. Three days training is required in the use of the Addiction 
Severity Index and it is available free of charge. 
 
The interviewer estimates an overall rating of severity. The ASI also includes a rating 
by the client on their estimation of problem severity. A Composite Score is calculated 
for each scale and a total Composite Score calculated for the sum of the Interviewer 
Severity Rating Scales. Questions for each scale require the client to comment both on 
problems over the past 30 day period and over the course of their lifetime.  
 
Extensive research has been carried out on the psychometric properties of the ASI.  
There are many studies that report on the content validity of the ASI (Alterman et al., 
1998; Carey, Cocco, & Correia, 1997; McLellan et al., 1985; Wertz, Cleaveland, & 
Stephens, 1995; Alterman, Brown, Zaballero, & McKay, 1994; Zanis, McLellan, 
Cnaan, & Randall, 1994; &  McLellan, Luborsky, Woody, & O'Brien, 1980). The fact 
that it was developed by clinical researchers who have extensive experience in the 
AOD field, and that it has been so widely adopted, are testimony to its content 
validity. Some studies have criticised certain scales of the ASI as being irrelevant to 
particular populations such as the homeless and the severely psychiatrically impaired 
(Carey et al., 1997).   
 
The ASI has been found to have reasonable construct validity in a number of studies 
(Alterman et al., 1998; Appleby, Dyson, Altman, & Luchins, 1997;  De Jong, 
Willems, Schippers, & Hendricks, 1995; Joyner, Wright, & Devine, 1996;  Argeriou, 
McCarty, Mulvey, & Daley, 1994; Zanis et al., 1994;  Hodgins & El-Guebaly, 1992;  
Hendricks, Kaplan, Van Limbeek, & Geerlings, 1989; Rogalski, 1987; McLellan, et al 
1985; Kosten, et al 1983; McLellan et al., 1980). However, Carey, Correia, & Cocco, 
Carey et al., (1997) found the construct validity to be poor in a psychiatric population. 
 
Criterion/concurrent validity is reported as being in the moderate range when the ASI 
is compared with independent variables matching the subscales, and also when 
compared with other similar instruments (Alterman et al., 1998; Appleby, et al 1997; 
Argeriou et al., 1994; Kosten, Rounsaville, & Kleber, 1983; McLellan et al., 1985; & 
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McLellan et al., 1980). Daepen et al., (1996) found the criterion validity of the ASI to 
be weak in a French speaking alcohol dependent population. Zanis, McLellan, & 
Corse (1997) found weak criterion validity with a population having a severe & 
persistent mental disorder and substance abuse problem. Wertz, Cleaveland, & 
Stephens (1995) also report weak criterion validity of the ASI. Overall the criterion 
validity as reported in the majority of studies is adequate. 
 
Item reliability has been reported as moderate to good in most studies (Argeriou et al., 
1994; Appleby et al., 1997; Zanis et al., 1997; De Jong et al., 1995; Alterman et al., 
1994; McCusker, Bigelow, Servignon, & Zorn, 1994; Zanis et al., 1994; Hodgins & 
El-Guebaly, 1992; Hendricks et al., 1989; & McLellan et al., 1980).  
 
Test-retest reliability has been reported as moderate to high for Composite scores and 
generally lower for Interviewer Severity Ratings (Carey et al., 1997; Zanis et al., 
1997; Daepen et al., 1996; Joyner et al., 1996; Drake, McHugo, & Besanz, 1995; 
McCusker et al., 1994; Zanis et al., 1994; & McLellan et al., 1985).  
 
Inter-rater reliability has been reported as being good to very good in most studies for 
the composite scores (Appleby et al., 1997; Carey et al., 1997; Zanis et al., 1997; 
Wertz et al., 1995;  Alterman et al., 1994; McCusker et al., 1994; Stoffelmayr, Mavis, 
& Kasim, 1994; Hodgins & El-Guebaly, 1992; & McLellan et al., 1980). Interviewer 
Severity ratings tend to be more subjective than Composite scores and higher 
variability has been found. These scores have thus been found to be less 
stable/reliable across interviewers and over time.  
 
Generally the ASI has been found to be quite sensitive to change in a number of 
studies (Argeriou et al., 1994; & Appleby et al., 1997). 
 
Health of the Nation Outcome Scale (HoNOS)  
Wing, J, K. Beevor, A, S. Curtis, R, H. (1998) 
 
The HoNOS  (Wing et al., 1998) is a scale developed by clinicians in the United 
Kingdom as a tool for measuring the general health and social functioning of mentally 
ill people. The HoNOS consists of an overall score of severity derived from 12 scales; 
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aggression, self harm, alcohol and drug, memory/orientation, physical problems, 
mood disturbance, hallucination and delusions, other mental, social relationships, 
social environment. These 12 scales can be grouped into 4 categories or sub-scales; 
behaviour, impairment, symptoms and social. The HoNOS takes 15-30 minutes to 
complete and must be administered by a trained clinician. The HoNOS is available 
free of charge. 
 
Several studies investigating the reliability and validity of the HoNOS have been 
reported in the literature. The results indicate that the HoNOS has satisfactory to good 
content, construct and criterion validity (Amin et al., 1999; Bebbington, Brugha, Hill, 
Marsden, & Window, 1999; Orrell, Yard, Handysides, & Schapira, 1999; & Wing et 
al., 1998). Results on reliability are mixed.  
 
Generally test-retest and item reliability are moderate to good (kappa 0.4 – 0.8) 
(Orrell et al., 1999; Wing et al., 1998). Inter-rater reliability reports are lower and are 
explained as 'possibly being due to insufficient agreement/understanding between 
raters on the standard of reference for each question's validity (Amin et al., 1999; 
Orrell et al., 1999; Wing et al., 1998). Bebbington, et al (1999) report quite poor inter-
rater reliability for the HoNOS. 
 
Sensitivity of the HoNOS to change has been reported as fairly good (Sharma, 
Wilkinson, & Fear, 1999). Some studies however indicate that the HoNOS does not 
register subtle changes in functioning (Stein, et al 1999). 
 
The HoNOS is a brief global assessment of functioning that can measure clinical 
change (Chaplin & Perkins, 1999; Sharma et al., 1999; & Taylor & Wilkinson, 1997). 
It does not provide information on specific areas of client need or on how change was 
facilitated. HoNOS scores can be a useful measure of change, or lack of change, 
provided they are collected at set intervals & by trained raters with established 
reliability’ (Sharma et al., 1999). 
 
In summary the HoNOS is a brief measure of clinical change that has been proven to 
be reliable and valid when used with a psychiatric population. It has as yet to be tested 
more comprehensively on a wider range of populations such as those abusing 
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substances and/or multi-cultural populations. It is important to stress the need for 
clinicians to be trained in the use of this instrument in order to gain valid and reliable 
data on client progress. Whilst the HoNOS has been shown to be sensitive to change, 
it does not aid in treatment planning and its major utility is as a gross measure of 
treatment effectiveness/client change over time. 
 
The Opiate Treatment index (OTI) 
Darke, Ward, Hall, Heather & Wodak, 1991 
 
The Opiate Treatment Index (OTI) was developed in Australia in 1991. It was 
developed as a measure of treatment outcome for the population of opiate users. The 
OTI was developed for use as both a clinical and a research tool. This instrument was 
developed in the form of a structured clinical interview and takes approximately 20 – 
30 minutes to administer. The OTI consists of questions that focus on AOD use, HIV 
risk taking behaviour, criminal behaviour, social functioning and psychological 
functioning. All of the questions except for social functioning refer to the month prior 
to the interview. 
 
Several studies examining the psychometric properties of the OTI have been reported 
in the literature. The OTI has been found to have reasonable internal reliability 
(Adelekan, 1996; Adelekan, 1996b; Darke et al., 1992;  & Darke, Ward, Zador, & 
Swift, 1991). 
 
Test retest reliability has been demonstrated to be adequate in the 2 studies that 
examined this issue (Adelekan, 1996; & Darke et al., 1992). Similarly Inter rater 
reliability has been shown to be good to very good (Adelekan, 1996; Adelekan, 
1996b; Deering & Sellman, 1996; &  Darke et al., 1992) 
 
Studies by Darke et al (1992) and Darke et al (1991) have found that the OTI has 
good content/ construct validity. Adelekan (1996) and Darke et al (1992) confirm the 
criterion validity of the OTI. 
 
Few published studies have focused on the ability of the OTI to register clinical 
change over time. However the OTI has been utilised extensively in clinical research.    
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The Short-Form 36 Health Survey (SF-36) 
Ware & Sherbourne (1992) 
 
The SF 36 is a self-administered questionnaire that was developed in 1992 as part of a 
study in the US to evaluate services in the health care system. It consists of 36 
questions that reflect the client’s functioning status, symptoms/well being and overall 
health. The SF 36 has 8 multi item scales; physical functioning, physical role 
limitation, emotional role limitation, bodily pain, mental health, social functioning, 
vitality and general health perceptions. This instrument takes approximately 5 – 10 
minutes to complete.  The scores are summed for each item, but an overall score is not 
calculated. Rather a profile for scores on the different dimensions is used. 
 
The SF 36 has been adapted for use in a number of countries. The internal reliability 
is acceptable (Sanson-Fisher & Perkins, 1998; Jenkinson, Coulter, & Wright, 1993; &  
Garratt, Ruta, Abdalla, Buckingham, & Russell, 1993) and test-retest reliability of the 
SF 36 are reported to be good (Sanson-Fisher & Perkins, 1998;  & Brazier et al., 
1992). 
 
Content and construct validity of the SF 36 has been shown to be quite high (Sanson-
Fisher & Perkins, 1998; Jenkinson et al., 1993; Garratt et al., 1993; & Brazier et al., 
1992) Tests of criterion validity are scarce, however Brazier et al (1992) have 
demonstrated good validity in this area in their study. 
 
There is published data on norms for the SF 36 (Aronson et al, 1992) and the SF 36 
has been shown to be sensitive to change (Rost, Smith, Burnam, & Burns, 1992). The 
SF-12 is a shorter version of this instrument that has been used extensively as an 
outcome tool. Whilst the SF-36  and the SF-12 do not register quantity and or 
frequency data on alcohol or other drug use, they cover every other important domain 
that a routine outcome assessment tool would need to access. 
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CONCLUSION 
 
In conclusion, this report clearly establishes the importance of routine outcome 
measurement. It is an essential tool for clinicians as it enables an objective assessment 
of treatment. Clinicians thereby have access to information that can serve as feedback 
for the effectiveness of a particular treatment/service and the potential need for 
modification of treatment services. 
 
Routine outcome measurement also provides an important source of information for 
clients. Assessment of outcome provides clients with objective evidence of the 
improvement in their health, validating and reinforcing gains that have been made 
during treatment. 
 
Assessment of outcome allows comparison of treatment across services. This can help 
in the process of standardising treatment services and assisting less functional services 
to adopt processes that have been proven to be more effective in services treating a 
similar population. In addition the information that is generated from routine outcome 
assessment can assist funding bodies to channel funds into areas where outcome is 
poor, with the aim of either improving existing treatments or developing and 
implementing new/more efficacious treatments. 
 
This project identified four outcome measures that could potentially be used in routine 
clinical outcome measurement. None of these instruments would be suitable to be 
utilised in their current format. They are either too long and labour intensive (ASI, 
OTI), require too much training for a reliable result (ASI), do not provide consistent 
enough results (HoNOS), or are too general (HoNOS, SF36). 
 
In light of the above discussion, one of these instruments would be suitable to be used 
in a modified version. The OTI is the obvious choice as it was developed specifically 
for use with the alcohol and other drug population. Exactly how this instrument would 
be modified is the subject for further investigation. Obviously a modified version 
would need to be briefer, reflect use of all substances and be validated via correlation 
with other major instruments outlined above. Possibly some component of client 
satisfaction with treatment could be added. 
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This study succeeded in identifying potential outcome measures and providing a 
recommendation as to an instrument that may be used for routine outcome 
assessment. This recommendation is a minimum recommendation. There are many 
instruments capable of detecting statistically and clinically significant change in 
clients with an alcohol or drug use disorder.  
 
Any of these instruments could be used in addition to the recommended measure in 
order to enhance the findings and identify more specific domains of treatment 
success/failure.  
 
Questionnaires that assess risk of relapse, instruments that reflect changes in 
depression and/or anxiety and biological measures can all be used in addition to the 
recommended minimum measure. The basic instrument, being multi-dimensional, is 
capable of assessing outcome in clients with AOD problems only as well as clients 
with a co-morbid psychiatric condition. Additional instruments can be used, however, 
in order to gain a more comprehensive profile of a particular client or client group.  
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Appendix 1:  
Complete list of instruments 
 
Name of Instrument Reference 
Addiction Research Centre Inventory  (Wilkinson, 1998) 
Addiction Research Foundation Clinical Institute 
Withdrawal Assessment-Alcohol 
(Alen, 1995) 
Addiction Severity Index & Follow-up form  (McLellan et al., 1980) 
Adolescent Alcohol Involvement Scale (Mayer & Filstead, 1979) 
Adolescent Diagnostic Interview (Winters & Henly, 1993) 
Adolescent Drinking Index  (Harrell & Wirtz, 1989) 
Adolescent Drug Abuse Diagnosis (Friedman & Utada, 1989; Friedman, Granick, & 
Kreisher, 1994) 
Adolescent Problem Severity Index (Metzger, Kushner, & McLellan, 1991) 
Adolescent Relapse Coping Questionnaire (Myers, Martin, Rosenow, & Monti, 1996) 
Adolescent Self Assessment Profile (Wanberg, 1991) 
Alanine Aminotransferase  (Burge & al., 1997) 
Alcohol Abstinence Self-Efficacy Scale (DiClemente et al., 1994; Parvin, 1998) 
Alcohol Beliefs Scale (Connors, O’Farrell, & Cutter, 1987) 
Alcohol Craving Questionnaire (Potgeiter, Deckers, & Geerlings, 1999) 
Alcohol Dependence Scale  (Skinner, 1984; Ross, Gavin, & Skinner, 1990;& 
Allen, Ferig, Towle, Altshuler, & al., 1994)  
Alcohol Effects Questionnaire (Brown , 1980) 
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Alcohol Effects Scale (Allen, 1995) 
Alcohol Expectancy Questionnaire (Brown, Christiansen, & Goldman, 1987) 
Alcohol Expectancy Questionnaire-Adolescent (Brown et al., 1987) 
Alcohol Problems Inventory (Stockwell, Bolt, Milner, Pugh, & Young, 1990) 
Alcohol Problems Questionnaire  (Drummond & Glautier, 1994; Thom et al., 1992; & 
Williams & Drummond, 1994) 
Alcohol Use Disorder and Associated Disabilities 
Interview-Alcohol/Drug Revised 
(Ustun et al., 1997) 
Alcohol Use Disorders Identification Test (Saunders et al., 1993; Conigrave, Hall, & 
Saunders, 1995; & O'Hare & Sherrer, 1999)  
Alcohol Use Inventory  (Wanberg, Horn, & Foster, 1977; Lee & diClemente, 
1985; & Rohsenow, 1982) 
Alcoholics Anonymous Affiliation Scale (Humphries, Kaskutas, & Wesner, 1998) 
Alcoholics Anonymous attendance  (Besson & al., 1998) 
Alcohol-Related Harm Scale (Rehm, Frick, & Bondy, 1997) 
Alcohol-related Problems Screening Questionnaire  (Ryder, Lenton, Harrison, & Dorricott, 1988) 
American Drug & Alcohol Survey (Peters, Oetting, & Edwards, 1992) 
Areas of Change Questionnaire  (McCrady, Stout, Noel, Abrams, & Nelson, 1991) 
Aspartate aminotransferase  (Wetterling, Anitz, H., Hapke, & Fischer, 1998) 
Beck Anxiety Inventory (Steer & Beck, 1997) 
Beck Depression Inventory - self-report  (Steer, Cavalieri, Leonard, & Beck, 1999) 
Beck Hopelessness Scale  (Steer & Beck, 1997) 
Benzodiazepine Dependence Questionnaire (Baillie & Mattick, 1996; &,Baillie, 1996) 
Binge drinking episodes in past month  (Fleming, Barry, & Johnson, 1997)  
Biochemical measures of nicotine use  (Dawe , & Mattick,  1979) 
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Biphasic Alcohol Effects Scale BAES   (Martin, Earlywine, Musty, Perrine, & al., 1993) 
Blood Alcohol Levels  (Wolff et al., 1999) 
Brief Drinker Profile  (Senft, Polen, Freeborn, & Hollis, 1997) 
Brief Psychiatric Rating Scale  (McGorry & Goodwin, 1988) 
Brief Symptom Inventory (from SCL-90) (Derogatis & Savitz, 1999) 
CAGE  (Ewing, 1984; Mischke & Venneri, 1987; & Bisson, 
Nadeau, & Demers, 1999) 
Camelback Vista Self Assessment and 
Management Scale 
(Little, 1990) 
Canterbury Alcoholism Screening Test (Elvy & Wells, 1984) 
Carroll Rating Scale for Depression (Carroll, Feinberg, Smouse, Rawson, & Greden, 
1981) 
Centre for Epidemiological Studies Depression 
Scale CES-D  
(Radloff, 1977) 
Chemical Dependency Adolescent Assessment 
Project 
(Harrell, Honaker, & Davis, 1991) 
Children of Alcoholics Information Test (NIAAA, 1995) 
Children of Alcoholics Screening Test (NIAAA, 1995) 
Circumstances, Motivation, Readiness, and 
Suitability 
(de Leon et al., 1995) 
Client Satisfaction Questionnaire  (Larsen, Attkisson, Hargreaves, & Nguyen, 1979; 
Attkisson & Zwick, 1983; & Greenwood, Key, Burns, 
Bristow, & Sedgwick, 1999) 
Clinical Alcoholism Interview Schedule (Caetano, Edwards, Openheim, & Taylor, 1978) 
Clinical Global Impression Scale (Pelc et al., 1997) 
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Cocaine & Sexuality Questionnaire (Hoffman, Mayo, Koman, & Claudill, 1994) 
Cocaine Craving Questionnaire  (Smelson, McGee-Caulfield, Bergstein, & 
Engelhart, 1999) 
Cocaine Effect Expectancy Questionnaire (Schaefer & Fals-Stewart, 1993) 
Cocaine Negative Consequences Checklist (Michalec et al., 1996) 
Cocaine Relapse Interview (McKay et al., 1996) 
Cocaine Risk Response Test (Carroll et al., 1999) 
Cocaine Selective Severity Assessment (Kampman et al., 1998) 
Collateral Interview Form (Long, Williams, & Hollin, 1998) 
College Alcohol Problem Scale (O'Hare, 1997)  
College Behaviour Questionnaire (Kahn, Maher, & Bornstein, 1973) 
Completing treatment  (Hayashida et al., 1989)  
Complications  seizures, DTs, death during 
treatment   
(Hayashida et al., 1989)  
Composite International Diagnostic Interview  (Robins et al., 1989) 
Composite International Diagnostic Interview - 
Substance Abuse Module (CIDI-SAM) 
(Sobell, Toneatto, & Sobell, 1994; Wittchen, 1994; 
& Cottler et al., 1997) 
Composite Outcome Measure (Cisler & Zweben, 1999)  
Comprehensive Addiction Severity Index for 
Adolescents 
(Meyers, McLellan, Jaeger, & Pettinati, 1995; & 
Whitmore et al., 1997) 
Comprehensive Drinker Profile & Follow-up Profile (Miller & Marlatt, 1984; &  Skutle & Berg, 1987) 
Contemplation Ladder (Sobell et al., 1994)  
Controlled Drinking Self-Efficacy Scale  (Kavanagh, Sitharthan, & Sayer, 1996; &  
Sitharthan & Kavanagh, 1990)  
Coping Behaviours Inventory  (Ito & Donovan, 1990) 
   68
   
Cumulative Abstinence Duration  (Potgeiter et al., 1999) 
Customary Drinking and Drug Use Record (Brown et al., 1998; Stewart & Brown, 1995; & 
Stewart, Brown, & Myers, 1997) 
Dartmouth Assessment of Lifestyle Instrument (Rosenberg et al., 1998),  
Days of heavy drinking over a fixed period  eg 6 
months   
(O'Malley et al., 1996)  
Denial Rating Scale (Newsome & Ditzler, 1993)  
Depression Adjective checklist (McDowell & Newell, 1996)  
Depression, Anxiety, Stress Scale  (Lovibond & Lovibond, 1995) 
Desire for Alcohol Questionnaire (Love & Willner, 1998) 
Desire to Use Drugs Inventory  (Rhoades, Creson, Elk, Schmitz, & Grabowski, 
1998) 
Diagnostic Interview Schedule  (Burge & al., 1997)  
Digit Symbol Test  (Rainer, Mucke, Chwatal, & Havelec, 1996) 
Dose Adequacy Questionnaire (Strain, Stitzer, Liebson, & Bigelow, 1993)  
Drinker Inventory of Consequences (Miller, Tonigan, & Longabaugh, 1995) 
Drinking and Craving Questionnaire (Ludwig & Stark, 1974) 
Drinking days per week  (Poldrugo, 1997) 
Drinking Expectancy Questionnaire (Young & Knight, 1989) 
Drinking Problems Index (Allen, 1995)  
Drinking Refusal Self-Efficacy Questionnaire (Allen, 1995)  
Drinking Survey  (Richmond, Heather, Wodak, Kehoe, & al., 1995)  
Drinking-Related Locus of Control (Koski-Jannes, 1994)  
Drinks per day  (Poldrugo, 1997)  
Drug & Alcohol Problem Quick Screen (Schwartz & Wirtz, 1990)  
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Drug Abuse Inventory (NIAAA, 1995)  
Drug Abuse Screening Test (Gavin, Ross, & Skinner, 1989) 
Drug Abuse Treatment for AIDS Risk Reduction 
Intake Form 
(Richard, Montoya, Nelson, & Spence, 1995) 
Drug Avoidance Self-Efficacy Scale  (Martin, Wilkinson, & Poulos, 1995)  
Drug Effects Questionnaire (Fischman, Schuster, & Hatano, 1983) 
Drug Impairment Scale for Cocaine (Halikas, Crosby, & Nugent, 1992)  
Drug Use Scale (Baker, Heather, Wodak, Dixon, & Holt, 1993)  
Drug Use Screening Inventory (Tarter & Hegedus, 1991;Tarter, Mezzich, Kirisci, & 
Kaczynksi, 1994; & Tarter, 1990) 
DSM-IV criteria (Diagnostic and statistical manual of mental 
disorders, 1994) 
Dyadic Adjustment Scale  (Jensen, Witcher, & Upton, 1987) 
Dysfunctional Attitudes Scale  (Brown, Kessel, Lourie, & Ford, 1997)  
Effectiveness of Coping Behaviours Inventory (ARF, 1993)  
Effects of Drinking Alcohol  (Sobell et al., 1994)  
Emergency department  casualty  visits (Fleming et al., 1997)  
Employee Reliability Inventory (Borofsky & Garely, 1995)  
Excessive Drinker Outcome Expectations Scale (Rollnick, Morgan, & Heather, 1996) 
Excessive drinking in past week  (Fleming et al., 1997) 
Expected Treatment Outcome Survey (Alemi, 1995)  
Expired Air Carbon Monoxide (Dawe , & Mattick,  1979) 
Fagerstrom Test for Nicotine Dependence (Rev of 
FTQ) 
(Kozlowski, Porter, Orleans, Pope, & 
Heatherington, 1994; Heatherington et al., 1991; & 
Pomerleau, Carton, Lutzke, Flessland, & 
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Pomerleau, 1994)  
Fagerstrom Tolerance Questionnaire (Kozlowski et al., 1994)  
Family Environment Scale  (Moos & Moos, 1986) 
Family Relationship Inventory (Stewart & Brown, 1993)  
Follow-Up Drinker Profile  (Alen, 1995) 
Form 90 (Tonigan, Miller, & Brown, 1997; & Miller & Del 
Boca, 1994)  
Gamma-glutamyl transpeptidase   (Wetterling et al., 1998) 
General Behaviour Inventory (Depue, Krauss, Spoont, & Arbisis, 1989) 
General Health Questionnaire  (Goldberg, 1972; Hupert, Walters, Day, & Elliot, 
1989; & Winefiled, Goldney, Winefield, & 
Tiggemann, 1989) 
Global Assessment Scale (Endicott et al., 1976; Dill, Eisen, & Grob, 1989) 
Global other-ratings  (Ling, Charuvastra, Collins, Batki, & al., 1998)  
Global self-rating of severity of drug problem  (Ling et al., 1998)  
Guttman Scale of Adolescent Substance Use (Andrews, Hops, Ary, & Lichtenstein, 1991) 
Hair analysis  (Wolff et al., 1999) 
Halikas-Crosby Drug Impairment Rating Scale for 
Cocaine 
(Halikas et al., 1992)  
Hamilton Anxiety Scale (Malyszak, Kiejna, & Grzesiak, 1998) 
Hamilton Rating Scale for Depression  (Hamilton, 1967) 
Health and Fitness Questionnaire  (Rowland, Dickinson, Newman, & Ford, 1994) 
Health Behaviour Questionnaire (Donovan, Jessor, & Costa, 1989) 
Health Questionnaire (Brodman, Erdman, Lorge, & Wolff, 1949) 
Heavy Smoking Index (2 Qs from FTND only) (Kozlowski et al., 1994) 
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Helping Alliance Questionnaire (Luborsky, Barber, Siqueland, & Johnson, 1996; & 
Belding, 1997 l 
Hilton Drinking Behaviour Questionnaire (Hilton & Lokare, 1978) 
HIV Risk-Taking Behaviour Scale - in OTI (Baker et al., 1993)  
Hospital Anxiety and Depression Scale (Snaith, 1984) 
Hospital days  (Fleming et al., 1997)  
Impaired Control Questionnaire  (Heather, Tebbutt, Mattick, & Zamir, 1993) 
Inventory of Drinking Situations  (Anis, 1982) 
Inventory of Drug-Taking Situations  (Annis & Graham, 1991) 
Iowa Stages Index (Finney, Hahn, & Moos, 1996) 
Latency to drinking at a particular level (Drummond & Glautier, 1994) 
Latency to first drink  (Sass, Soyka, Mann, & Zieglgansberger, 1996)  
Latency to first morning drink  (Drummond & Glautier, 1994)  
Latency to first withdrawal  (Drummond & Glautier, 1994)  
Learned Helplessness Scale  (Verma, Mahajan, & Verma, 1998) 
Leeds Dependence Questionnaire (Raistrick et al., 1994; Raistrick et al., 1983; & 
Lennings, 1999) 
Le-Go Grid (NIAAA, 1995)  
Life Stressors and Social Resources Inventory (Moos & Moos, 1997) 
Liver Function Tests  (Dawe , & Mattick,  1979) 
Locke-Wallace Marital Adjustment Test  self and 
spouse   
(McCrady et al., 1991)  
Lubeck Craving Scale (Potgeiter et al., 1999)  
MacAndrew Alcoholism Scale  (MacAndrew, 1965; Weed, Butcher, & Williams, 
1993; & Knowles & Shroeder, 1990) 
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Manifest Anxiety Scale (Kaliappan, Rajalakshmi, & Sarada, 1982) 
Marijuana Craving Questionnaire CPDD Abstracts p60 
Marijuana Effect Expectancy Questionnaire (Schafer & Brown, 1991) 
Marital Adjustment Test  (Maisto, McKay, & O'Farrell, 1998)  
Marital separation  (Rotunda & O'Farrell, 1997)  
Maudsley Addiction Profile  (Marsden et al., 1998)  
Maudsley Personality Inventory (Woody, McLellan, Luborsky, & O'Brien, 1987)  
Mean corpuscular volume  (Besson & al., 1998)  
Mean days marital separation  (McCrady et al., 1991)  
Medical Outcomes Study Short Form Health Survey (Brazier et al., 1992) 
Medication Side Effects Questionnaire  (Rhoades et al., 1998)  
Michigan Alcohol Screening Test - MAST & SMAST 
& Brief MAST & Self-administered AST & Malmo 
Modification 
(Selzer, 1971; Gibbs, 1983; & Storgaard, Nielsen, & 
Gluud, 1994) 
Michigan Alcoholism Screening Test for Significant 
Others 
(NIAAA, 1995)  
Millon Clinical Multiaxial Inventory-II & III (Craig, 1999; McMahon & Richards, 1996;& Flynn, 
McCann, Luckey, Rounds-Bryant, & al., 1997a) 
MMPI-derived Scales - Hampton AL - Hoyt & 
Sedlacek AH - Holmes & Burton AM - Mac - Mac+L 
– Rosenberg Composite 
(NIAAA, 1995)  
Montgomery-Asberg Depression Rating Scale (Bowling, 1991) 
Montgomery-Asberg Depression Rating Scale  (Naranjo, Donigier, & Bremmer, 1997)  
Mood Adjective Checklist  (Cruickshank, 1978) 
Mortimer-Filkins Questionnaire  (Mischke & Venneri, 1987) 
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Motivational Structure Questionnaire (Cox & Klinger, 1988) 
Multimedia Assessment of Student health (Dimeff, 1998) 
Munich Alcoholism Test (Benforado, 1982) 
Natural History Interview  (Grella, Anglin, & Wugalter, 1997)  
Negative Alcohol Expectancy Questionnaire (McMahon & Jones, 1993) 
NET (Bottoms, .S., & Sokol, 1989) 
Newcastle Alcohol-related Problems Scale  (Ryder et al., 1988)  
Nicotine Withdrawal Checklist (Smith, Pristach, & Cartagena, 1999)  
Nottingham Health Profile (Hunt et al., 1981;&  Doll, Black, Flood, & 
McPherson, 1993) 
Obsessive-Compulsive Drinking Scale (Anton, Moak, & Latham, 1995) 
One/Two Questions  (Sobell et al., 1994)  
Opiate Treatment Index (Darke et al., 1992) 
Opiate Withdrawal Symptom Checklist (Schottenfeld, Pakes, Oliveto, Ziedonis, & Kosten, 
1997)  
Opiate Withdrawal Symptoms  (Kahn et al., 1973)  
Parental Drinking Questionnaire (NIAAA, 1995)  
Perceived Benefit of Drinking Scale (Petchers & Singer, 1987) 
Percent days abstinent  (Brown et al., 1997)  
Personal Experience Inventory (Winter & Henly, 1989) 
Personal Experience Inventory for Adults (Winter & Henly, 1989) 
Personal Experience Scales (NIAAA, 1995)  
Personal Experience Screening Questionnaire (Winter & Henly, 1989) 
Personal Experience with Living Scale (NIAAA, 1995)  
Personal Involvement With Chemicals Scale (Winters & Henly, 1987) 
   74
   
Pleasant Events Schedule-Mood Related  (Brown et al., 1997)  
Problem Drinking Questionnaire (Hanna, 1978) 
Problem Recognition Questionnaire (Cady, Winters, Jordan, Solberg, & Stinchfield, 
1996)  
Problem Severity Index (Dobkin, Chabot, Maliantovich, & Craig, 1998)  
Problem Situation Inventory (Hawkins, Catalano, & Wells, 1986) 
Problems Oriented Screening Instrument for 
Teenagers 
(Hall, Richardson, Spears, & Rembert, 1998)  
Proceeding to treatment from detoxification  (Hayashida et al., 1989) 
Processes of Change Inventory for Opiate Addicts (Tejero, Trujols, Hernandez, de los Cobos, & 
Casas, 1997) 
Profile of Mood States (Lorefice, Steer, Fine, & Schut, 1976) 
Psychiatric Symptom Assessment Scale (Bigelow & Berthot, 1989) 
Psychosocial Functioning Inventory  (Timberlak & Verdieck, 1987) 
Purpose in Life Test (Waisberg & Porter, 1994)  
Quantity, frequency and patterning of drug use  (Chang & Dodder, 1983) 
Quantity-Frequency methods (smoking) (Dawe , & Mattick,  1979) 
Questionnaire of Alcohol Urges  (Modesto-Lowe, Burleson, Hersh, Bauer, & 
Kranzler, 1997)  
RAND Definite Alcoholism (Finney et al., 1996)  
RAND overall impairment (Finney et al., 1996)  
RAND serious symptoms (Finney et al., 1996)  
Readiness to Change Questionnaire  (Rollnick, Heather, Gold, & Hall, 1992)  
Recovery Attitude and Treatment Evaluation 
Research Scale 
(Mee-Lee, 1988) 
   75
   
Relapse latency  (Besson & al., 1998)  
Relapse Situation Appraisal Questionnaire (Myers et al., 1996) 
Resistance to Continuing Care (McKay, Alterman, McLellan, & Snider, 1994)  
Resistance to Treatment (McKay et al., 1994) 
Revised Fagerstrom Tolerance Questionnaire  (Kozlowski et al., 1994) 
Rhode Island Change Assessment (Willoughby & Edens, 1996) 
Risk Behaviour Inventory (Ottomanelli, Heller, Bihari, & Kramer, 1989) 
Risk for AIDS Behaviour Inventory (Sands, Archer, & Puleo, 1998)  
Rosenberg Self-Esteem Scale  (Dobson, Goudy, Keith, & Powers, 1979) 
Rutgers Alcohol Problem Index (White & Labouvie, 1989) 
Schedule for Affective Disorders and Schizophrenia (Woody et al., 1987)  
Schedules for Clinical Assessment in 
Neuropsychiatry 
(Ustun et al., 1997)  
Screening, Women and Alcohol in Goeteborg (Spak & Haellstroem, 1996)  
Self-Administered Questionnaire (Bull, Kvigne, Leonardson, Lacina, & Welty, 1999) 
Self Administered Alcohol Screening Test (Swenson & Morse, 1975) 
Self-Help Group Beliefs Subscale (McKay et al., 1994)  
Self-Help Group Participation Subscale (McKay et al., 1994) 
Self-monitoring for alcohol intake (Kavanagh et al., 1996)  
Self-Rating Form (Richard et al., 1995) 
Service Satisfaction Scale 30 (Greenfiled & Attkisson, 1999) 
Severity of Alcohol Dependence Questionnaire (Stockwell, Sitharthan, McGrath, & Lang, 1994; 
Dawe , & Mattick,  1979; & Doherty & Webb, 1989) 
Severity of Dependence Scale  (Gossop et al., 1995; Topp & Mattick, 1997; & 
Oberg, Andren, Ronnberg, & Stenstrom, 1995) 
   76
   
Severity of Opiate Dependence Scale (Sutherland et al., 1986; Sutherland, Edwards, 
Taylor, Phillips, & Gossop, 1988; & Burgess, Stripp, 
Pead, & Holman, 1989) 
Shipley Institute of Living Scale (Woody et al., 1987)  
Short Alcohol Dependence Data Questionnaire  (Raistrick et al., 1983; 
Davidson & Raistrick, 1986;  &Davidson, 1987) 
Short-Form-20 Health Survey (Brazier et al., 1992) 
Short-Form-36 Health Survey (Brazier et al., 1992) 
Short Opiate Withdrawal Scale (Gossip, 1990) 
Situational Confidence Questionnaire  (Miller, Ross, Emerson, & Todt, 1989; & Kirisci, 
Moss, & Tarter, 1996) 
Situations for Drinking Questionnaire (Deardorff, Melges, Hout, & Savage, 1975) 
Social Adjustment Self-Report Questionnaire (Weissman, 1987) 
Social Avoidance (Anxiety) and Distress Scale (Sheikh & Kaushik, 1990) 
Social Support Appraisals Scale  (O'Reilly, 1995) 
Social Support Behaviours Scale (Vaux, Reidel, & Stewart, 1987) 
SSAGA (Bucholz, Gadoret, Cloninger, & Dinwiddie, 1994) 
Stable Recovery Period (Potgeiter et al., 1999)  
Stages of Change Readiness and Treatment 
Eagerness Scale 
(Hewes & Janikowski, 1998)  
State-Trait Anxiety Inventory (Spielberger) (Sielberger, Gorsuch, Vagg, & Jacobs, 1983) 
Straus-Bacon Index- measure of social stability  (Drummond & Glautier, 1994)  
Structured Clinical Interview for DSM-III-R (O'Malley et al., 1996)  
Student Alcohol Questionnaire (Engs & Hanson, 1994) 
Substance Abuse Attitude Survey (Chappel, Veach, & Krug, 1985) 
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Substance Abuse Subtle Screening Inventory (Cooper & Robinson, 1987) 
Substance Abuse Treatment Scale (McHugo et al., 1995) 
Substance Use Disorders Diagnostic Screening 
Test 
(Davis, Hoffman, Morse, & Luehr, 1992) 
Substance Use Index  (Sitharthan, Kavanagh, & Sayer, 1996)  
Substance Use Screening Instrument  (Oliansky, Wildenhaus, Manlove, Arnold, & 
Schoener, 1997) 
Symptom Checklist-90-Revised  (Derogatis, 1983; Mercier et al., 1992) 
Symptom Severity Checklist (Stockwell et al., 1990)  
Symptoms of Anxiety and Depression Scale (Bowling, 1991)  
T-ACE (Russell & Bigler, 1979) 
Teen-Addiction Severity Index (Kaminer et al., 1991; Kaminer, Wagner, Plummer, 
& Seifer, 1993;&Kaminer, Bukstein, & Tarter, 1989) 
Teen Health Advisor (Paperny, Aono, Lehman, Hammar, & Risser, 1990)
Temptation and Restraint Inventory (Collins & Lapp, 1992) 
Tennessee Self-Concept Scale (Hoffman & Gelen, 1983) 
The Khavari Alcohol Test (Khavari & Farber, 1973) 
The Marijuana Questionnaire (Hollister & Overall, 1975) 
The Missouri Alcoholism Severity Scale (Sexias, 1983) 
The Student Alcohol Questionnaire (Engs & Hanson, 1994) 
Time to the First Cigarette  (Sobell et al., 1994)  
Timeline Followback (Sobell & Sobell, 1992; Sobell & Sobell, 1992; 
Carey,1997) 
Torabi-Veenker Alcohol Attitude Scale (Torabi & Veenker, 1986) 
Trail Making Test  (Reitan, 1955) 
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Treatment Expectancy - single question   (Sitharthan et al., 1996)  
Treatment Follow-up Inventory (Stinchfield, Niforopulos, & Feder, 1994)  
Treatment Outcome Profile (Holcomb et al., 1997;Holcomb, Parker, Leong, 
Thiele, & Higdon, 1998) 
Treatment Satisfaction Scale (Lewis, Bradley, Knight, Boulton, & Ward, 1988) 
Tremor Index  (Zilm, Durand, & Kaplan, 1978) 
Trier Alcoholism Inventory (Berman, Hales, & Yudofsky, 1996) 
TWEAK  (Russell & Bigler, 1979; Cherpital, 1997; Allen, 
1995) 
University of Rhode Island Change Assessment (Willoughby & Edens, 1996) 
Urine analysis  (Dawe , & Mattick,  1979) 
Veterans Alcoholism Screening Test (Magruder, Harris, & Fraker, 1982) 
Visual Analogue Scale - to measure craving  (Besson & al., 1998)  
Voris Cocaine Craving Scale (Smelson et al., 1999)  
Weekly Drug Use Inventory (Schottenfeld et al., 1997)  
Withdrawal Symptom Checklist (Lader, 1983) 
Yale-Brown Obsessive-Compulsive Scale (Modell, Glaser, Mountz, & Schmaltz, 1992)  
Young Adult  Alcohol Problems Screening Test (Hurlbut & Sher, 1992) 
Zung's Self Rating Depression Scale (McDowell & Newell, 1996) 
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Appendix 2: Copies of Instruments A-D –  
a) Addiction Severity Index 
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Appendix 2: Copies of Instruments A-D –  
b) Health of the Nation Outcome Scales 
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Appendix 2: Copies of Instruments A-D –  
c) Opiate treatment Index 
Drug use section 
For full OTI refer to NDARC Technical Report No 11. 
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Appendix 2: Copies of Instruments A-D –  
d) Short-Form 36 
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Appendix 3:  
Copy of questionnaire rating form 
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